NCT00960219
D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia treatment 2 completed NCT00491569
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia treatment 2 completed NCT00276263
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia treatment 2 withdrawn NCT00328276
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia treatment 2 completed NCT00488319
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. treatment 3 completed NCT05164289
Interest of EMDR Schizophrenic Disorders No drug interventions Not Available Not Available terminated NCT00572247
The Psychiatric Rehabilitation Approach to Weight Loss No drug interventions Not Available Not Available completed NCT04608032
Neuropsychological Assessment of Remediation for Cognitive Impairments in Schizophrenia No drug interventions other Not Available recruiting NCT01606436
A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia basic_science 1 completed NCT02655172
Have a Good Grasp of the Worldthe World No drug interventions other Not Available completed NCT00660595
Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose treatment 3 terminated NCT02654405
Sodium Butyrate For Improving Cognitive Function In Schizophrenia No drug interventions treatment 2 / 3 withdrawn NCT00600756
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone treatment 3 completed NCT02525315
Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations No drug interventions treatment 2 completed NCT01279213
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia treatment 4 completed NCT02544516
Upside Down, Give me the Handle No drug interventions Not Available Not Available completed NCT00088465
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT00088491
Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia treatment 3 completed NCT01729650
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) No drug interventions prevention Not Available completed NCT00485823
Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia treatment 4 completed NCT00161408
Psychological Intervention for Relapse Prevention in First Episode Schizophrenia No drug interventions treatment Not Available unknown_status NCT01852331
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00206115
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia treatment 3 completed NCT00018837
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome No drug interventions Not Available Not Available completed NCT03010865
Sodium Butyrate For Improving Cognitive Function In Schizophrenia treatment 2 / 3 withdrawn NCT06617104
Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT00001246
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT00001247
Inpatient Evaluation of Adults With Schizophrenia No drug interventions Not Available Not Available recruiting NCT00001258
Studies of Frontal Lobe Brain Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT00001486
Genetic Study of Schizophrenia No drug interventions Not Available Not Available recruiting NCT00024622
PET Scanning in Parkinson s Disease No drug interventions Not Available Not Available recruiting NCT03183609
Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) No drug interventions treatment Not Available completed NCT03669250
CVN058 Effect on Mismatch Negativity in Schizophrenics No drug interventions treatment 1 completed NCT04506905
Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011) treatment 1 completed NCT04783571
Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia No drug interventions other Not Available recruiting NCT04846868
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1) treatment 3 active_not_recruiting NCT04846881
Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) treatment 3 active_not_recruiting NCT04860830
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia treatment 3 active_not_recruiting NCT05211947
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study treatment 3 recruiting NCT05303064
Study to Evaluate Weight Gain As Assessed by Change in BMI Z-score in Pediatric Subjects with Schizophrenia or Bipolar I Disorder treatment 3 recruiting NCT05968638
Ketogenic Diet in People With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT06628323
Neuro-VR: Augmenting a Virtual Reality-based Therapy with Neurofeedback for Auditory Hallucinations No drug interventions treatment Not Available not_yet_recruiting NCT06225115
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of KYN-5356 in Healthy Subjects Aged 18 to 55 Years No drug interventions treatment 1 active_not_recruiting NCT06361667
Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") No drug interventions treatment Not Available recruiting NCT06386588
The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia No drug interventions basic_science Not Available recruiting NCT04578756
Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder treatment 3 recruiting NCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? treatment 4 active_not_recruiting NCT05030272
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings treatment Not Available recruiting NCT05110157
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia treatment 3 recruiting NCT05145413
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia treatment 3 recruiting NCT05268809
Can Neural Network Instability in Schizophrenia Be Improved with a Very Low Carbohydrate Ketogenic Diet? No drug interventions basic_science Not Available recruiting NCT05304767
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia treatment 3 recruiting NCT05368558
Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia treatment 3 terminated NCT05469815
Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients No drug interventions other Not Available not_yet_recruiting NCT05480046
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse Not Available Not Available recruiting NCT05538832
Remote State Representation in Early Psychosis No drug interventions treatment 0 recruiting NCT05545111
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia No drug interventions treatment 2 completed NCT05643196
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia No drug interventions treatment 2 completed NCT05686239
A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) No drug interventions treatment 2 recruiting NCT05805397
Effectiveness of Motivation Skills Training (MST) No drug interventions treatment Not Available recruiting NCT06123897
Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort Study No drug interventions Not Available Not Available recruiting NCT06610500
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry No drug interventions Not Available Not Available completed NCT06179108
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia treatment 2 active_not_recruiting NCT06286202
Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial No drug interventions treatment Not Available recruiting NCT06315283
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia treatment 1 recruiting NCT06397950
Correlates of Fatigue in People With Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting NCT06446856
EVEN - Effects of VR on Empathy for Nature in Patients with Psychosis and Depressive Disorders No drug interventions Not Available Not Available completed NCT06474286
Prucalopride for Cognitive Functioning in Schizophrenia treatment Not Available not_yet_recruiting NCT06613334
Voice-Based Biomarkers: a Novel Approach to Monitoring and Predicting Schizophrenia Relapses No drug interventions other Not Available not_yet_recruiting NCT06586164
Enhancing Rehabilitation for Veterans With Serious Mental Illness No drug interventions treatment Not Available not_yet_recruiting NCT06588270
Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia No drug interventions treatment Not Available recruiting NCT06595654
Treatment of Negative Symptoms of Schizophrenia by rTMS No drug interventions other Not Available recruiting NCT06599372
Evaluation of the Efficacy of Transcranial Magnetic Stimulation on Resistant Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available recruiting NCT06603922
The Personalized Psychological Treatment for Psychosis No drug interventions treatment Not Available not_yet_recruiting NCT01567943
Contingency Management of Alcohol Abuse in the Severely Mentally ILL No drug interventions treatment Not Available completed NCT00440843
Zyprexa and Task Engagement in Schizophrenia treatment 3 withdrawn NCT00208143
Seroquel Therapy for Substance Use Disorders Comorbid With Schizophrenia treatment 4 completed NCT03446703
SCIT Versus TAR for Outpatients With Schizophrenia No drug interventions treatment Not Available completed NCT02001103
Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia treatment 3 unknown_status NCT00861003
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder No drug interventions Not Available Not Available unknown_status NCT05830903
Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques No drug interventions treatment Not Available recruiting NCT02625103
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. health_services_research 4 completed NCT01391403
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia treatment 3 completed NCT03285503
PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia other 1 completed NCT00053703
Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS) treatment 4 completed NCT03333603
Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients treatment 4 completed NCT05628103
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication treatment 3 completed NCT00307203
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke treatment 4 completed NCT04268303
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia treatment 3 completed NCT03090503
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up treatment 4 unknown_status NCT00108303
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes No drug interventions Not Available Not Available completed NCT02916303
Cost-effectiveness of Interventions in First-episode Psychosis No drug interventions Not Available Not Available unknown_status NCT03542903
ECT in Ultra-resistant Schizophrenia No drug interventions treatment Not Available unknown_status NCT01568203
First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia No drug interventions basic_science 1 terminated NCT01491490
Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine treatment 2 terminated NCT00448890
Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers No drug interventions treatment 1 completed NCT01409590
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications No drug interventions supportive_care Not Available completed NCT00922090
A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended No drug interventions Not Available Not Available completed NCT03999190
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia Not Available Not Available withdrawn NCT00585390
Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia treatment 2 / 3 completed NCT02986490
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs No drug interventions prevention Not Available unknown_status NCT01232790
A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia No drug interventions treatment Not Available completed NCT01143090
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT06504290
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 No drug interventions treatment 1 recruiting NCT05036590
Efficiency Assessment of BREFORM. A Multicentric Stepped-wedge Randomized Control Trial. No drug interventions other Not Available recruiting NCT00885690
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA) treatment Not Available terminated NCT00148590
Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia prevention 3 terminated NCT01897064
The Influence of Aerobic Exercise on Cognitive Functioning in Schizophrenia. No drug interventions treatment Not Available completed NCT03953664
The Effects of Three Different Modalities of Exercise in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00569764
Effect on Metabolic Parameters of Abilify in SPR No drug interventions Not Available Not Available unknown_status NCT03146364
Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia No drug interventions diagnostic Not Available unknown_status NCT00857064
Subjective Well Being of Schizophrenic Patients in Greece No drug interventions Not Available Not Available completed NCT00649064
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs treatment 4 completed NCT05542264
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia treatment 1 completed NCT01451164
A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia treatment 2 / 3 completed NCT00207064
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia diagnostic Not Available completed NCT01995864
Critical Time Intervention-Task Shifting: Randomized Controlled Trial No drug interventions health_services_research Not Available completed NCT02415764
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant No drug interventions health_services_research 1 completed NCT02105064
Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant Obsessive-compulsive Symptoms in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01955564
A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers. treatment 1 completed NCT02810964
Sulforaphane to Reduce Symptoms of Schizophrenia treatment 2 completed NCT05646264
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia treatment 4 recruiting NCT03302364
A Research in Pharmacogenomics and Accurate Medication of Risperidone Not Available Not Available unknown_status NCT00483964
A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia treatment 2 completed NCT02775864
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia Not Available Not Available completed NCT02764164
Transcranial Direct Current Stimulation (TDCS) for Auditory Hallucinations in Early Onset Schizophrenia (EOS) No drug interventions treatment Not Available terminated NCT03198364
Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI No drug interventions health_services_research Not Available completed NCT02484521
Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration No drug interventions basic_science Not Available completed NCT00088621
A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia treatment 2 completed NCT05516121
VLT-015 in Patients With Schizophrenia No drug interventions other 1 completed NCT00138021
Cognitive Remediation in Supported Employment at Human Service Center (HSC) No drug interventions treatment Not Available unknown_status NCT01891721
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT00290121
Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics prevention 4 completed NCT01317121
Multi-site Communication Deficits in Schizophrenia No drug interventions Not Available Not Available completed NCT00435721
Families Coping With Mental Illness Program No drug interventions educational_counseling_training 1 unknown_status NCT00892021
Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder No drug interventions other 1 withdrawn NCT06384521
Lifestyle MIND- Feasibility of Wait-list Control No drug interventions treatment Not Available not_yet_recruiting NCT00918021
Polypharmacy in Clozapine-resistant Schizophrenia treatment 4 completed NCT00685321
Tolerability, Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation in Subjects With Negative Symptoms and Cognitive Deficits of Schizophrenia No drug interventions treatment Not Available unknown_status NCT02968121
Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia health_services_research 1 terminated NCT04917302
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia No drug interventions treatment 2 recruiting NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain treatment 2 completed NCT00169702
The Effect of a Weight Management Program During Treatment With Olanzapine No drug interventions prevention Not Available completed NCT01315002
Nicotine Effects on Endophenotypes of Schizophrenia basic_science Not Available completed NCT00254202
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia treatment 3 completed NCT01733602
tDCS to Enhance Cognitive Training in Schizophrenia No drug interventions treatment 1 / 2 completed NCT02035202
Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness No drug interventions treatment Not Available completed NCT02650102
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment basic_science 1 / 2 unknown_status NCT00455702
Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia treatment 4 completed NCT00061802
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT06058702
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans other 1 not_yet_recruiting NCT03817502
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia treatment 3 recruiting NCT00211302
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) treatment Not Available terminated NCT00484302
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis No drug interventions treatment Not Available completed NCT01001702
Oral Aripiprazole Open-Label Rollover Study treatment 3 completed NCT00299702
Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia treatment 4 completed NCT01892384
Safety and Tolerability of BI 409306 in Patients With Schizophrenia treatment 1 completed NCT02287584
Confirmatory Study of DSP-5423P in Patients With Schizophrenia No drug interventions treatment 3 completed NCT02435784
The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong Kong No drug interventions supportive_care Not Available completed NCT06486584
Contingency Management for Problematic Behavior Reduction in the Community No drug interventions other Not Available active_not_recruiting NCT04012684
rTMS on Mismatch Negativity of Schizophrenia No drug interventions treatment Not Available unknown_status NCT05229484
Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia No drug interventions supportive_care Not Available completed NCT02687984
PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia treatment 1 completed NCT00848484
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED) No drug interventions treatment 2 completed NCT00791284
A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function treatment 1 completed NCT05957484
The Effects of Non-invasive Neuromodulation on Illness Awareness in Schizophrenia No drug interventions treatment Not Available recruiting NCT06067984
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT04781179
Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT04907279
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE) Not Available Not Available unknown_status NCT00463879
Galantamine for Cognitive Deficits in Schizophrenia treatment 2 / 3 completed NCT01249079
Expanding Rapid Ascertainment Network of Schizophrenia Families in Taiwan No drug interventions Not Available Not Available unknown_status NCT03178279
The Evaluation of the Use of a New Physical Health Plan No drug interventions health_services_research Not Available completed NCT03504579
Rt-fMRI Neurofeedback and AH in Schizophrenia No drug interventions other Not Available completed NCT00102479
Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents treatment 2 completed NCT06471179
Functional Magnetic Resonance Imaging Study in Schizophrenia Patients and Correlation With Cognitive Impairments No drug interventions Not Available Not Available not_yet_recruiting NCT00215579
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence treatment 4 completed NCT01003379
TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia treatment 2 completed NCT01160679
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT06226779
Baduanjin Versus Brisk Walking for Cognition in Schizophrenia No drug interventions treatment Not Available recruiting NCT00141479
To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox treatment 2 completed NCT00524979
Digital Voice Analysis in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT03338179
Evaluation of Metamemory in Patients With Schizophrenia No drug interventions basic_science Not Available completed NCT02398279
L-arginine add-on Therapy in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT02868879
Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and Cataphasia No drug interventions Not Available Not Available completed NCT01234779
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia treatment 2 completed NCT00604279
A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia treatment 3 completed NCT02127879
Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT01104779
Safety and Efficacy of Cariprazine in Schizophrenia treatment 3 completed NCT02199743
Lurasidone Effects on Tissue Glutamate in Schizophrenia treatment 4 completed NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia treatment 4 completed NCT00265343
6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) treatment 3 completed NCT00396643
Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis prevention 4 completed NCT02333487
Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700 No drug interventions treatment 1 completed NCT01758887
Antipsychotic Discontinuation in High-risk Subjects No drug interventions Not Available Not Available withdrawn NCT00044187
The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder treatment 4 completed NCT04158687
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia treatment 2 completed NCT00843687
A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients. treatment 3 completed NCT01133587
Patient Guided Psychiatric Admissions No drug interventions prevention Not Available completed NCT00236587
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia treatment 3 completed NCT00193687
Bifeprunox in the Treatment of Schizophrenia treatment 3 completed NCT02901587
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder treatment 1 completed NCT01315587
Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia No drug interventions treatment 2 unknown_status NCT00204087
Psychological Intervention for Persons in the Early Initial Prodromal State No drug interventions treatment 3 unknown_status NCT00493233
Antipsychotic Polypharmacy in Schizophrenia treatment Not Available completed NCT00051233
Treatment of Schizophrenia Through Internet-Based Psychoeducation No drug interventions treatment 2 completed NCT00692133
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment No drug interventions Not Available Not Available completed NCT00345033
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia treatment 4 completed NCT02254733
Assertive Community Treatment With CBT and SST for Schizophrenia No drug interventions treatment Not Available completed NCT00423033
Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients No drug interventions Not Available Not Available completed NCT03263533
HDAC Inhibitor Augmentation to Clozapine treatment 0 withdrawn NCT01945333
Personalized and Scalable Cognitive Remediation Approaches No drug interventions treatment Not Available completed NCT00069433
Enhancing the Outcome of Skills Training for People With Schizophrenia No drug interventions treatment Not Available completed NCT00615433
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia treatment 3 completed NCT06304233
The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease No drug interventions Not Available Not Available recruiting NCT05086133
cTBS on First-episode Drug Naive Patients With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT05174533
Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03702933
D-serine in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT01299454
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects treatment 1 completed NCT03935854
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness No drug interventions treatment Not Available completed NCT01244854
Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental Illness No drug interventions health_services_research Not Available completed NCT03526354
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder treatment 4 completed NCT01234454
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI basic_science Not Available completed NCT02050854
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia No drug interventions Not Available Not Available completed NCT00805454
Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712 basic_science 1 completed NCT04822051
The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia Caregivers No drug interventions supportive_care Not Available completed NCT03930251
Cognitive Remediation for Coordinated Specialty Care No drug interventions treatment Not Available completed NCT04987151
The Effects of Different Modalities of Exercise in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT00753051
Treat Clozapine ( CLZ )-Resistant Schizophrenia Comparing CLZ + Haloperidol vs. CLZ + Electroconvulsive Therapy (ECT) treatment Not Available completed NCT00758251
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment No drug interventions Not Available Not Available completed NCT01149551
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness No drug interventions Not Available Not Available completed NCT06275451
Qualitative Study of Emotional Regulation in Schizophrenia No drug interventions Not Available Not Available recruiting NCT00330551
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia treatment 4 completed NCT03414151
Gut Microbiome in AP Naive No drug interventions Not Available Not Available unknown_status NCT03629951
A Study for Schizophrenia Relapse Prediction No drug interventions Not Available Not Available completed NCT00300651
Trial of Cognitive Behavioral Therapy for Schizophrenia No drug interventions treatment 3 unknown_status NCT01006551
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders treatment 2 completed NCT00265551
Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia treatment 2 completed NCT05053451
Brain Stimulation, Clinical Symptoms and Cognition No drug interventions treatment Not Available completed NCT00419653
Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy treatment 4 terminated NCT01354353
A Study of Safety and Tolerability in Subjects With Schizophrenia other 1 completed NCT05724953
Alexithymia Intervention for Suicide No drug interventions treatment 1 recruiting NCT03973853
How Can a Driving Virtual Reality Tool Improve Quality of Life and Social Autonomy in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT01509053
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole treatment 3 terminated NCT00236353
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT03847753
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions No drug interventions Not Available Not Available completed NCT01454453
Optimisation of Antipsychotic Drug Use in Older People No drug interventions treatment 4 terminated NCT01609153
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy treatment 4 completed NCT03623477
Can Cognitive Training Decrease Reactive Aggression? No drug interventions treatment Not Available completed NCT01010477
Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia treatment 4 completed NCT04318977
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia No drug interventions treatment Not Available recruiting NCT05449977
Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00234377
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia treatment 3 completed NCT02476877
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse No drug interventions Not Available Not Available completed NCT01028677
Oxytocin Treatment of Schizophrenia treatment Not Available completed NCT00074477
Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00715377
Anticholinergic Burden in Schizophrenia treatment Not Available terminated NCT05345977
eMotiph: E-mental Health Solution for Patients With Schizophrenia No drug interventions device_feasibility Not Available completed NCT02505477
Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine treatment 4 completed NCT00391677
Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia No drug interventions treatment Not Available completed NCT01149577
Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients basic_science 4 completed NCT01400477
Nicotinic Receptors and Schizophrenia treatment 2 completed NCT00333177
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia treatment 4 completed NCT00590577
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia treatment 3 completed NCT01677377
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy treatment 2 completed NCT00621777
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder treatment 4 completed NCT00560677
Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study) No drug interventions Not Available Not Available unknown_status NCT01321177
An Integrated Program for the Treatment of First Episode of Psychosis No drug interventions treatment Not Available completed NCT04941677
Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control No drug interventions Not Available Not Available completed NCT00148447
The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia treatment 3 completed NCT02661347
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia treatment Not Available withdrawn NCT00141947
Bexarotene Treatment in Schizophrenia treatment 3 unknown_status NCT00174447
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 treatment 3 completed NCT00206947
The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia treatment 2 terminated NCT00403247
Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT01795547
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia treatment 3 completed NCT00145847
Naltrexone Treatment of Alcohol Abuse in Schizophrenia No drug interventions treatment 4 completed NCT02739347
Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia No drug interventions treatment Not Available terminated NCT05389345
tDCS and Executive Function Training for Schizophrenia No drug interventions treatment Not Available withdrawn NCT02288845
Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia basic_science 2 completed NCT02841345
Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic Patients No drug interventions basic_science Not Available unknown_status NCT03896945
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia No drug interventions treatment 2 / 3 terminated NCT02850445
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients treatment Not Available unknown_status NCT00641745
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia treatment 3 completed NCT00535145
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease treatment 4 completed NCT00864045
Sertindole in Asian Patients With Schizophrenia treatment 3 completed NCT05837598
Adapting the Tumor Board Model for Mental Illness and Cancer No drug interventions supportive_care Not Available recruiting NCT00818298
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study No drug interventions treatment Not Available completed NCT01310998
Acute Psychological Effects of High Intensity Exercise With Schizophrenia No drug interventions health_services_research Not Available completed NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia treatment 2 recruiting NCT01738698
Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia treatment 3 terminated NCT04040998
Compensatory Cognitive Training For Schizophrenia No drug interventions treatment Not Available completed NCT01866098
Naltrexone for Antipsychotic-Induced Weight Gain treatment Not Available completed NCT00051298
Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia treatment 3 completed NCT01749098
A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers basic_science 1 completed NCT04629898
Level of Immersion of Virtual Reality and Cognition and Motor Performance in Patients of Schizophrenia Spectrum Disorder No drug interventions health_services_research Not Available completed NCT04495998
The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia No drug interventions supportive_care Not Available completed NCT03940898
The Mid-term Effect of Repeated Transcranial Magnetic Stimulation on Schizophrenia No drug interventions treatment Not Available completed NCT00338598
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism treatment 2 completed NCT00001198
Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia No drug interventions Not Available Not Available terminated NCT02332798
Multiple Ascending Doses of PF-04958242 in Subjects With Stable Schizophrenia treatment 1 completed NCT03166098
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders No drug interventions Not Available Not Available completed NCT05859698
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia treatment 4 active_not_recruiting NCT01595698
Schizophrenia and Physical Exercise No drug interventions treatment Not Available completed NCT04510298
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia No drug interventions treatment 1 completed NCT00534898
Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients treatment 3 withdrawn NCT01361698
Illness Management and Recovery (IMR) in Danish Community Mental Health Centres No drug interventions treatment Not Available completed NCT00486798
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis treatment 3 terminated NCT00875498
Intermittent Theta Burst Stimulation (iTBS) for the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT02591498
Computerized Cognitive Training for Schizophrenia in Brazil No drug interventions treatment 3 unknown_status NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder treatment 3 unknown_status NCT01527305
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia treatment 4 completed NCT02970305
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) treatment 2 completed NCT00227305
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder treatment 3 completed NCT00757705
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia treatment 4 completed NCT06007105
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities No drug interventions supportive_care Not Available recruiting NCT00772005
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia treatment 2 completed NCT01323205
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia treatment 2 completed NCT00528905
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia treatment 2 completed NCT01214005
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls No drug interventions basic_science 2 completed NCT00761605
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants treatment 4 completed NCT00034905
A Comparison of Seroquel vs. Risperidone in Schizophrenia treatment 4 completed NCT00757497
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia No drug interventions treatment 1 terminated NCT01699997
Oxytocin as Adjunctive Therapy for Schizophrenia treatment 2 completed NCT03860597
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia supportive_care 4 completed NCT04268797
TMS in Treatment of Schizophrenia Negative Symptoms No drug interventions treatment Not Available unknown_status NCT00861497
Bifeprunox Extension to Extension Study in Patients With Schizophrenia treatment 3 terminated NCT02686697
Carnosine and Cognitive Training in Schizophrenia treatment 2 / 3 completed NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia treatment 2 / 3 completed NCT06494397
Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions treatment 1 not_yet_recruiting NCT06021197
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia No drug interventions treatment 2 recruiting NCT04147897
Implementing mHealth for Schizophrenia in Community Mental Health Settings No drug interventions treatment Not Available active_not_recruiting NCT03509597
Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia No drug interventions treatment Not Available unknown_status NCT00392197
Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism- treatment 4 completed NCT06045897
EEG Microstates Across At-Risk Mental States No drug interventions diagnostic Not Available recruiting NCT02357797
Adjunctive Vortioxetine in Schizophrenia treatment 4 active_not_recruiting NCT00063297
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia No drug interventions treatment 2 completed NCT01810783
Brexpiprazole in Patients With Schizophrenia treatment 3 completed NCT02930083
Validating Three Common Occupational Therapy Assessments in Participants With Schizophrenia No drug interventions Not Available Not Available completed NCT01487083
A Long-Term Study in Schizophrenia treatment 3 terminated NCT05380583
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot Study No drug interventions treatment Not Available recruiting NCT00044083
Clinical Trial of Tolcapone for Cognition in Schizophrenia other 2 terminated NCT04822883
Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia No drug interventions treatment 2 completed NCT00536783
Schizophrenia Sensory Gating Deficit With Quetiapine Not Available Not Available completed NCT00197483
Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia Not Available Not Available suspended NCT05936983
Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia No drug interventions Not Available Not Available completed NCT00856583
Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use prevention 3 completed NCT00148083
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia treatment 3 completed NCT01032083
Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia treatment 4 completed NCT02621983
Aerobic Exercise for Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT03617783
Prebiotic Treatment in People With Schizophrenia - Pilot Study No drug interventions other 4 completed NCT00204061
Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis treatment 4 completed NCT05667961
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation No drug interventions Not Available Not Available recruiting NCT04562961
Diagnostic Announcement to Relatives of Patients With Schizophrenia No drug interventions other Not Available unknown_status NCT00012961
Improving Health Services for Veterans With Schizophrenia No drug interventions Not Available Not Available completed NCT00561561
Sensorimotor Gating in Schizophrenia No drug interventions basic_science Not Available completed NCT06276361
Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia treatment 1 recruiting NCT00937261
Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) Scanning treatment 4 unknown_status NCT02282761
A Trial to Assess the Antipsychotic Efficacy of ITI-007 treatment 3 completed NCT00587561
Efficacy of Social Cognition Training in Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT00237861
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia treatment 4 completed NCT04659161
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2) treatment 3 completed NCT01714661
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy treatment 3 completed NCT05784961
Impact of tDCS on Cannabis Craving in Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT02360228
STimulation to Improve Auditory haLLucinations No drug interventions treatment Not Available completed NCT00048828
Treating Drug-Resistant Childhood Schizophrenia treatment 4 completed NCT00444028
Staccato Loxapine Single Dose PK treatment 1 completed NCT05712928
eMove - Dance/Movement Therapy Study No drug interventions treatment Not Available completed NCT05571228
Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis No drug interventions treatment Not Available active_not_recruiting NCT03588728
tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia No drug interventions treatment Not Available terminated NCT05623228
The Effectiveness and Efficacy of the Combination of the Integrated Psychological Therapy and Metacognitive Training. No drug interventions treatment 2 completed NCT05537428
Song-making In a Group (SING) No drug interventions basic_science Not Available completed NCT01446328
Bergen Psychosis Project 2 - The Best Intro Study treatment 4 completed NCT02694328
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) treatment 3 completed NCT00511628
Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia Not Available Not Available terminated NCT01246128
Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics No drug interventions Not Available Not Available withdrawn NCT01568528
Oxytocin as Adjunctive Treatment of Schizophrenia treatment 2 completed NCT02075528
Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER treatment 4 completed NCT01805128
Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum No drug interventions Not Available Not Available completed NCT00988728
Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) treatment 2 withdrawn NCT02007928
Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic No drug interventions other Not Available completed NCT00728728
Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia treatment 2 completed NCT03817528
ITI-007 (Lumateperone Tosylate) for Schizophrenia treatment 2 terminated NCT04418011
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum Disorders No drug interventions treatment Not Available completed NCT02124811
Minocycline Augmentation to Clozapine treatment 4 completed NCT01972711
Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics treatment 1 completed NCT05402111
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard treatment 1 completed NCT00168311
A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT00615511
Efficacy of Pregnenolone in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00510211
An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. Not Available Not Available completed NCT00975611
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation treatment 4 terminated NCT03788811
ERG Components in Schizophrenia and Bipolar Disorder Type I No drug interventions Not Available Not Available active_not_recruiting NCT01610011
Acute Glycine Pharmacodynamic Study No drug interventions basic_science Not Available completed NCT05580211
Neuromodulation for Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT06251193
Optimizing CBSST With Executive Function Training for Schizophrenia No drug interventions treatment Not Available recruiting NCT02455193
Neuronal Effects of Exercise in Schizophrenia No drug interventions other Not Available recruiting NCT01329393
Benefits Management for People With Psychiatric Disabilities No drug interventions treatment 1 completed NCT00650793
A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia treatment 3 completed NCT04113993
Bazedoxifene -Treatment for Women With Schizophrenia treatment 4 recruiting NCT00952393
Nicotinic Receptors and Schizophrenia treatment 1 completed NCT00791193
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR treatment 1 completed NCT04605393
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study basic_science Not Available completed NCT01328093
A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients treatment 3 terminated NCT06370793
Ningbo Schizophrenia Cohort No drug interventions Not Available Not Available active_not_recruiting NCT00197093
In-Patient Study In Schizophrenic Patients treatment 1 completed NCT00043693
Family Intervention for Mental Illness and Substance Abuse No drug interventions treatment Not Available completed NCT01614093
Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia treatment 4 completed NCT01585493
CHANGE -it is About Life No drug interventions prevention 3 completed NCT00216671
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode treatment 4 completed NCT02950571
RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting No drug interventions supportive_care Not Available completed NCT05498571
Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00001771
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers No drug interventions Not Available Not Available completed NCT01541371
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia treatment 3 completed NCT06387771
Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia treatment 2 recruiting NCT00212771
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) treatment 3 completed NCT01670071
A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia treatment 4 terminated NCT00000371
Trial of D-Cycloserine in Schizophrenia treatment 3 completed NCT04076371
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia treatment Not Available completed NCT03132571
Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia treatment 2 terminated NCT02118571
Schizophrenia Cognition Scale Development No drug interventions Not Available Not Available completed NCT01425671
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States No drug interventions Not Available Not Available completed NCT02634671
Perception of Facial Emotions in Schizophrenia and 22q11 Deletion Syndrome No drug interventions diagnostic Not Available completed NCT00480571
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder treatment 2 completed NCT01378078
Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00923078
Neurophysiological Targets for Cognitive Training in Schizophrenia No drug interventions treatment Not Available completed NCT01821378
Lurasidone Low-Dose - High-Dose Study Study treatment 3 completed NCT03528278
Using Motivational Techniques to Increase Levels of Physical Activity in Long Term Psychiatric Inpatient Wards No drug interventions Not Available Not Available completed NCT00214578
Seroquel on Glucose Metabolism treatment 4 completed NCT03198078
Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia treatment 3 completed NCT03751488
A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients treatment 1 completed NCT02983188
Berberine as Adjuvant Treatment for Schizophrenia Patients treatment 2 / 3 completed NCT00203788
Improving Work Outcome in People With Recent-onset Schizophrenia treatment 4 completed NCT03757988
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life No drug interventions treatment Not Available completed NCT00507988
Complex Problem Solving Training in Schizophrenic Patients No drug interventions treatment Not Available completed NCT02140788
Effects of Metformin and Fish Oil on Treatment With Clozapine other 4 terminated NCT04038788
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00543088
Effectiveness of Anti-Psychotic in GPs Setting No drug interventions Not Available Not Available completed NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia treatment 4 completed NCT04432688
The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients Not Available Not Available completed NCT01282307
Improving Insight in Patients Diagnosed With Schizophrenia No drug interventions treatment Not Available completed NCT02245607
Compensatory Cognitive Training in Clinical High Risk Latino Youth No drug interventions treatment Not Available unknown_status NCT01888107
Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT01903707
Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available unknown_status NCT04094207
Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia treatment 1 / 2 completed NCT05866107
App and Body Fat Scale in the Management of Overweight Patients No drug interventions treatment Not Available not_yet_recruiting NCT05766007
Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum No drug interventions Not Available Not Available recruiting NCT00919607
Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients Not Available 1 completed NCT00458107
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects No drug interventions treatment 1 completed NCT00202007
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia treatment 2 completed NCT06361407
Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia No drug interventions basic_science Not Available not_yet_recruiting NCT05833009
Acupuncture Treatment for Schizophrenia-related Central Obesity No drug interventions treatment Not Available recruiting NCT05106309
Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants treatment 1 completed NCT03862209
Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (RECOVER-E) Croatia No drug interventions health_services_research Not Available unknown_status NCT04430309
Baduanjin on Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT01177709
Metformin for Weight Loss in Schizophrenia treatment Not Available terminated NCT00237809
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia treatment 3 completed NCT00870909
Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT04820309
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5) treatment 3 completed NCT03854409
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder basic_science 1 completed NCT02511509
Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT00798109
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse No drug interventions treatment Not Available completed NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophrenia treatment 3 completed NCT06431009
The Danish Region Midt Schizophrenia Cohort No drug interventions Not Available Not Available recruiting NCT00453609
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) treatment 4 completed NCT02568709
Oxytocin MEG Study treatment 0 completed NCT03003156
50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia No drug interventions treatment Not Available completed NCT04421456
Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment treatment 2 terminated NCT02233556
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects Not Available Not Available unknown_status NCT04203056
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode treatment 4 terminated NCT00239356
Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials treatment 3 completed NCT01874756
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia treatment 2 terminated NCT01876056
Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis No drug interventions treatment Not Available completed NCT02151656
F17464 in Acute Schizophrenia Trial No drug interventions treatment 2 completed NCT02308956
Task Sharing for the Care of Severe Mental Disorders in a Low-income Country No drug interventions health_services_research 3 completed NCT06176456
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia No drug interventions treatment Not Available recruiting NCT00481156
Functional Neuroimaging Effects of Cognitive Remediation Training No drug interventions basic_science 3 completed NCT00737256
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence treatment 2 unknown_status NCT00001656
Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders treatment 4 completed NCT00119756
A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia treatment 3 completed NCT01235585
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) treatment 3 completed NCT03790085
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals diagnostic 0 unknown_status NCT04783285
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic Disorders No drug interventions treatment Not Available completed NCT00221585
The National Danish Schizophrenia Project No drug interventions Not Available Not Available unknown_status NCT00046085
Online Family Support and Education for Schizophrenia No drug interventions treatment Not Available completed NCT00796185
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations treatment 1 completed NCT05850585
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia treatment Not Available not_yet_recruiting NCT01626885
A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia treatment 2 / 3 completed NCT03571685
Sustainable Early Episode Clinic Study (SEEC) No drug interventions other Not Available completed NCT06527885
Lurasidone Non-Interventional Study in Schizophrenia Patients Not Available Not Available completed NCT01034085
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT01392885
Brain Health and Exercise in Schizophrenia No drug interventions Not Available Not Available recruiting NCT02282085
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia treatment 4 unknown_status NCT05725785
Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness No drug interventions supportive_care Not Available recruiting NCT03000985
Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms No drug interventions supportive_care Not Available unknown_status NCT03359785
A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia treatment 2 completed NCT01411085
Risperidone and Desipramine in Alcohol Use and Schizophrenia treatment 2 completed NCT00455715
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia treatment 4 completed NCT03708315
BXCL501 for Agitation in Schizophrenia treatment 2 recruiting NCT03781115
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia diagnostic 1 unknown_status NCT01686815
Cross-Sectional Iloperidone IVGTT No drug interventions Not Available Not Available completed NCT00395915
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia treatment 4 unknown_status NCT01383915
Clinical Risk State for Bipolar Disorder in Adolescents No drug interventions Not Available Not Available active_not_recruiting NCT01529515
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia No drug interventions treatment 3 completed NCT01047215
Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine treatment 4 unknown_status NCT01903915
Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02131415
Real Life Assessment of Abilify Maintena No drug interventions Not Available Not Available terminated NCT04611737
Self-Determination Theory and Motivational Interviewing No drug interventions supportive_care Not Available completed NCT01903837
A Study of ALKS 3831 in Adults With Schizophrenia treatment 2 completed NCT03873337
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) treatment Not Available completed NCT01953237
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications No drug interventions health_services_research Not Available completed NCT02647437
Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia other Not Available recruiting NCT02205437
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00668837
A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305. treatment 3 completed NCT03943537
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders other 2 recruiting NCT00139737
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia treatment 3 completed NCT01611337
Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry No drug interventions other Not Available completed NCT00619437
Genetics of Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00560937
Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia treatment Not Available completed NCT02832037
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia No drug interventions treatment 2 completed NCT02567032
Adult Study Oxytocin - Behavioral treatment 0 completed NCT04959032
Lumateperone for the Prevention of Relapse in Patients With Schizophrenia treatment 3 active_not_recruiting NCT00216632
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) treatment 4 completed NCT02002832
A Clinical Trial of Lurasidone in Treatment of Schizophrenia treatment 3 completed NCT02652832
Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels No drug interventions basic_science Not Available unknown_status NCT01663532
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia treatment 3 completed NCT02533232
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia treatment 1 unknown_status NCT01952132
Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects treatment 2 completed NCT03978832
Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone treatment 4 completed NCT05823532
Anti-Inflammatory Challenge in Schizophrenia basic_science 4 recruiting NCT01003132
Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis No drug interventions treatment Not Available completed NCT05017532
Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders No drug interventions treatment Not Available recruiting NCT02626832
Regulation of Arginine-vasopressin (AVP) No drug interventions diagnostic Not Available completed NCT05074732
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study. No drug interventions Not Available Not Available recruiting NCT00249132
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia treatment 3 completed NCT03237052
Validating and Optimizing Model of Antipsychotics Selection No drug interventions treatment Not Available unknown_status NCT00839852
A Study of Cariprazine in Patients With Chronic Stable Schizophrenia treatment 2 completed NCT00495352
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia treatment 4 completed NCT04941352
Motivational Interviewing in Patients With Schizophrenia No drug interventions supportive_care Not Available completed NCT00644852
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone No drug interventions Not Available Not Available completed NCT05929352
Song-making In a Group (SING) No drug interventions basic_science Not Available recruiting NCT00980252
Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention No drug interventions Not Available Not Available completed NCT02104752
Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia treatment 1 / 2 completed NCT00328952
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00287352
Study of Amantadine for Weight Stabilization During Olanzapine Treatment treatment 1 completed NCT03425552
A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment other 1 / 2 completed NCT02876900
Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia. treatment 3 completed NCT00013000
A Multi-Site Study of Strategies for Implementing Schizophrenia Guidelines No drug interventions treatment Not Available completed NCT01479400
Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study No drug interventions Not Available Not Available completed NCT00802100
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia treatment 4 completed NCT01779700
Fingolimod in Schizophrenia Patients treatment 2 completed NCT03711500
D-serine Augmentation of Neuroplasticity treatment 1 / 2 completed NCT00686400
A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia No drug interventions Not Available Not Available unknown_status NCT05848700
A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia treatment 1 completed NCT00847600
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia No drug interventions treatment 4 completed NCT05435300
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT01348100
Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients treatment 1 / 2 completed NCT02640300
Switching Antipsychotics: Abrupt Discontinuation Versus Overlap treatment 4 completed NCT00174200
Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone treatment Not Available completed NCT03568500
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic health_services_research 4 completed NCT00829400
Cognitive Training to Enhance VA Work Program Outcomes No drug interventions treatment Not Available completed NCT06440200
Exploring the Health Effects of Group Game-based Activities on Individuals With Chronic Mental Illness No drug interventions other Not Available enrolling_by_invitation NCT04191200
Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital No drug interventions Not Available Not Available completed NCT04951700
Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia No drug interventions Not Available Not Available recruiting NCT01626859
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia treatment 2 / 3 completed NCT02796859
Siltuximab in Schizophrenia treatment 1 / 2 recruiting NCT03788759
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia treatment 2 / 3 completed NCT02932059
Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia No drug interventions other Not Available unknown_status NCT00740259
Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol treatment 4 completed NCT01503359
Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia No drug interventions treatment 2 completed NCT01981759
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions treatment 4 completed NCT01561859
Brain Imaging, Cognitive Enhancement and Early Schizophrenia No drug interventions treatment Not Available completed NCT01940159
A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia treatment 1 completed NCT02676375
Nicotine Receptor Density & Response to Nicotine Patch: Pt 2 Extended Treatment treatment 4 completed NCT00960375
Smoking Cessation for Veterans With Severe and Persistent Mental Illness No drug interventions treatment 2 / 3 completed NCT02067975
Tryptophan MRI in People With Schizophrenia and Healthy Controls treatment 2 / 3 completed NCT00338975
Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With Schizophrenia No drug interventions treatment Not Available completed NCT00306475
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? treatment 4 completed NCT04350775
Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia No drug interventions treatment Not Available completed NCT00712075
Functional Rehabilitation for Older Patients With Schizophrenia No drug interventions treatment Not Available terminated NCT02660775
Social Cognitive Assessment in Autism and Schizophrenia No drug interventions screening Not Available completed NCT00517075
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS) No drug interventions treatment 2 terminated NCT00138775
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia treatment 2 unknown_status NCT01100775
Effects of Galantamine on Cognition prevention 2 completed NCT05124470
Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients No drug interventions basic_science Not Available completed NCT05463770
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia treatment 1 completed NCT00333970
Predictors of Response to Cognitive Remediation in Schizophrenia No drug interventions treatment Not Available completed NCT01973270
Community-Based Cognitive Training in Early Schizophrenia No drug interventions treatment Not Available completed NCT00579670
Treatment of Schizophrenic Patients With Ziprasidone Not Available Not Available completed NCT03221270
Targeting Auditory Hallucinations With Alternating Current Stimulation No drug interventions treatment Not Available completed NCT05643170
An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia treatment 3 terminated NCT00259870
SB-773812 Administered In Adults With Schizophrenia treatment 2 completed NCT03048370
Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia No drug interventions basic_science Not Available completed NCT00761670
Efficacy Study on Cognitive Functions in Schizophrenic Patients treatment 4 completed NCT01078870
Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype diagnostic 4 unknown_status NCT00538070
A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia No drug interventions treatment Not Available completed NCT00788970
Shiatsu Adjuvant Therapy And Placebo For Schizophrenia No drug interventions treatment Not Available unknown_status NCT02477670
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia No drug interventions treatment 2 completed NCT00809770
Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill No drug interventions treatment Not Available completed NCT02267070
Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode No drug interventions treatment Not Available completed NCT00929370
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam. treatment 1 terminated NCT01121042
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia treatment 3 completed NCT01634542
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia No drug interventions Not Available Not Available completed NCT02782442
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) No drug interventions treatment Not Available completed NCT02636842
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder treatment 1 completed NCT00487942
Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits treatment 2 completed NCT02417142
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia treatment 4 completed NCT03575442
"Art Therapy" in Acute Psychiatry No drug interventions screening Not Available unknown_status NCT00182442
Cognition, Functioning and Quality of Life treatment 4 completed NCT01169142
Study of Vitamin D in the Severely Mentally Ill No drug interventions treatment 4 completed NCT01244542
Pain and Schizophrenia No drug interventions health_services_research Not Available terminated NCT00018642
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder treatment Not Available completed NCT00538642
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone treatment Not Available completed NCT01387542
Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants treatment 4 completed NCT00108199
Generalization of Training in Schizophrenia No drug interventions Not Available Not Available completed NCT00457899
Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder treatment 3 terminated NCT01545999
Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT01614899
A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia treatment 3 completed NCT00782899
Four Dimensions in Schizophrenia No drug interventions Not Available Not Available completed NCT02439099
Retinoic Acid Homeostasis in Neuropsychiatric Diseases No drug interventions Not Available Not Available unknown_status NCT00425399
Shiatsu Adjuvant Therapy For Schizophrenia No drug interventions treatment Not Available completed NCT05358899
Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia No drug interventions treatment Not Available recruiting NCT01137799
The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients treatment 1 terminated NCT01870999
A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot treatment 1 completed NCT02108899
Retrieval Practice and Schizophrenia No drug interventions supportive_care Not Available suspended NCT03497299
Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia No drug interventions treatment 2 withdrawn NCT00645099
A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With Schizophrenia treatment 3 completed NCT00286299
Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia No drug interventions treatment Not Available completed NCT01448499
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients treatment Not Available withdrawn NCT01898299
TDCS for Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT00823199
An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia No drug interventions treatment Not Available completed NCT00567099
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole treatment Not Available unknown_status NCT01511406
Cognitive Behavioral Therapy for Patients With an Early Psychosis No drug interventions treatment 2 completed NCT01368406
Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia No drug interventions prevention Not Available completed NCT00563706
Study Evaluating Vabicaserin in Subjects With Schizophrenia treatment 2 completed NCT03852706
EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED) No drug interventions other Not Available terminated NCT00789906
Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT05662306
C-Cog in Early Course Schizophrenia Study treatment 4 recruiting NCT00611806
Effectiveness of Vitamin Supplementation in Treating People With Residual Symptoms of Schizophrenia No drug interventions treatment 4 completed NCT00470106
Improving Basic and Social Cognition in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT02121106
Remote Cognitive Remediation No drug interventions treatment Not Available completed NCT00139906
Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia treatment 2 completed NCT01192906
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) treatment 3 completed NCT00753506
Artemisinin to Reduce The Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT03068806
Brain Imaging, Attention, and Auditory Processing in Schizophrenia No drug interventions Not Available Not Available completed NCT06043206
Bariatric Surgery in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04598906
Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and Depression No drug interventions treatment Not Available completed NCT00155506
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios No drug interventions Not Available Not Available completed NCT05663749
Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics treatment 4 completed NCT01057849
Standard Comprehensive Intervention to Treat First-episode Schizophrenia treatment Not Available unknown_status NCT01094249
A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder Not Available 1 completed NCT04752449
Virtual Cognitive Behavioural Therapy for Psychosis No drug interventions treatment Not Available active_not_recruiting NCT00088049
Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia treatment 4 completed NCT00731549
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia treatment 3 completed NCT00232349
Efficacy of Galantamine to Treat Schizophrenia treatment 4 terminated NCT01312649
Feeling of Being in Control of One's Own Action No drug interventions basic_science Not Available completed NCT02507349
Person-Centered Versus Measurement-Based Care in Mental Health No drug interventions treatment Not Available completed NCT02160249
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) No drug interventions supportive_care Not Available completed NCT01298349
Perception Processing in Schizophrenia Patients and Normal Population No drug interventions Not Available Not Available completed NCT00312949
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia No drug interventions Not Available Not Available completed NCT06315049
Music Therapy to Reduce Anxiety in Community-Dwelling Individuals With Severe Mental Illness No drug interventions supportive_care Not Available completed NCT02663349
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness No drug interventions treatment Not Available completed NCT00338949
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes treatment 4 completed NCT03481049
Individualizing Incentives for Alcohol in the Severely Mentally Ill No drug interventions treatment Not Available active_not_recruiting NCT02768649
Single Ascending Dose Study of RBP-7000 treatment 1 completed NCT01111149
Varenicline and Smoking Cessation in Schizophrenia treatment 2 completed NCT05159349
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia No drug interventions Not Available Not Available recruiting NCT00392249
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial. No drug interventions treatment 1 / 2 unknown_status NCT03881449
DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole treatment 4 unknown_status NCT00155649
A Positional Cloning Study on Schizophrenia No drug interventions Not Available Not Available completed NCT00873249
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00268749
Glycine Treatment of Prodromal Symptoms treatment 2 completed NCT04476836
Animal-Assisted Therapy in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT03208036
Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness No drug interventions treatment Not Available completed NCT00155636
A Study on Etiological Factors of Schizophrenia No drug interventions Not Available Not Available terminated NCT05351736
Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) other 4 recruiting NCT06003036
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine No drug interventions basic_science Not Available recruiting NCT00212836
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) treatment 3 completed NCT02435836
A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia treatment 3 terminated NCT00392236
Improving Medication Adherence Among People With Schizophrenia Through the Use of 2-way Pagers No drug interventions supportive_care Not Available completed NCT01534936
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary No drug interventions Not Available Not Available completed NCT00253136
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia treatment 3 completed NCT00063336
Treatment Response to Rehabilitation in Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00320736
Galantamine for Cognition in People With Schizophrenia treatment 4 completed NCT01213836
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia treatment 4 completed NCT00314613
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal treatment 4 terminated NCT00791713
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER treatment 1 completed NCT00309413
A Clinical Trial on the Antipsychotic Properties of Cannabidiol No drug interventions treatment 2 completed NCT04284813
Families With Substance Use and Psychosis: A Pilot Study No drug interventions treatment Not Available completed NCT02815813
Lifestyle Intervention for Young Adults With Serious Mental Illness No drug interventions treatment Not Available completed NCT03049813
Virtual Reality Job Interview Training in Severe Mental Illness No drug interventions other Not Available completed NCT06245213
A Study of ANAVEX3-71 in Adults With Schizophrenia treatment 2 recruiting NCT01926613
Thinking Skills for Work in Severe Mental Illness No drug interventions treatment Not Available completed NCT00237913
Schizophrenia Trial of Aripiprazole treatment 3 completed NCT02202213
Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia No drug interventions treatment 1 completed NCT04742413
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study. No drug interventions Not Available Not Available terminated NCT02102113
Probing the Cannabinoid System in Individuals With a Family History of Psychosis other 0 active_not_recruiting NCT01623713
Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia treatment 2 completed NCT00102518
Aripiprazole Open-Label, Safety and Tolerability Study treatment 3 completed NCT00549718
Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia treatment 3 completed NCT00531518
Early Detection and Intervention for the Prevention of Psychosis prevention Not Available completed NCT03503318
Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia treatment 3 completed NCT00006418
Molecular Genetics of Schizophrenia No drug interventions Not Available Not Available completed NCT01477918
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea No drug interventions Not Available Not Available unknown_status NCT05660018
TMS Related Biomarker Assessments No drug interventions other Not Available recruiting NCT02161718
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder treatment 2 completed NCT04093518
Estradiol as add-on to Antipsychotics treatment 3 unknown_status NCT00495118
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. treatment 3 completed NCT02322918
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder No drug interventions Not Available Not Available unknown_status NCT02134418
Evaluation of Social Skills Intervention on Cognitive Function in Schizophrenia No drug interventions supportive_care Not Available unknown_status NCT00827918
A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004) treatment 2 completed NCT05328518
Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients. No drug interventions Not Available Not Available recruiting NCT00501618
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder basic_science 4 completed NCT01822418
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) treatment 4 completed NCT00218218
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia basic_science 2 completed NCT02378818
Characterization of the Motivational Deficit in Schizophrenia and Depression No drug interventions basic_science Not Available unknown_status NCT05207319
Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia No drug interventions supportive_care Not Available completed NCT00155519
A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological Dysfunctions No drug interventions Not Available Not Available completed NCT01731119
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents treatment 2 completed NCT04294719
A Study of Cognitive Adaptation Training in Inpatient Forensic Environments No drug interventions Not Available Not Available completed NCT02360319
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics health_services_research 4 completed NCT01943019
Linagliptin in Schizophrenia Patients treatment 1 terminated NCT00269919
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia treatment 4 completed NCT01381419
First Time in Human Study (FTIH) With Positron Emission Tomography (PET) No drug interventions treatment 1 completed NCT02853019
Emotion and Motivation in Patients With Psychosis No drug interventions other Not Available recruiting NCT00659919
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone treatment 4 completed NCT01452919
A Physical Dependence Study in Schizophrenia treatment 3 completed NCT04115319
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia. treatment 3 completed NCT00611741
The Effect of Plasma Osmolality on Brain Glutamate Not Available 1 completed NCT01549041
Once-Daily Asenapine for Schizophrenia treatment 4 completed NCT03370341
Stimulating the Brain to Improve Self-Awareness No drug interventions basic_science Not Available completed NCT05473741
Risk of Breakthrough Symptoms With Long-Acting Injectable Medications Not Available Not Available recruiting NCT01512641
Prevalence of Dissociative Disorders in Children No drug interventions diagnostic Not Available completed NCT02823041
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode No drug interventions treatment Not Available completed NCT03523741
Therapeutic Drug Monitoring for Individualized Clozapine Therapy Not Available Not Available unknown_status NCT00078741
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness No drug interventions treatment 2 completed NCT05779241
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005 treatment 3 completed NCT00447941
Safety, PK and PD Study in Healthy Male Japanese Subjects No drug interventions treatment 1 completed NCT06199817
The Effect Of Multiple Occupational Therapies On Functional Remission And Subjective Recovery For Schizophrenia No drug interventions supportive_care Not Available completed NCT01886417
Auditory Verbal Hallucinations in Schizophrenia No drug interventions Not Available Not Available completed NCT01123317
Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia basic_science Not Available withdrawn NCT02366117
Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems No drug interventions Not Available Not Available unknown_status NCT00167817
Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study treatment 4 completed NCT02237417
Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism treatment 4 completed NCT01915017
Interventions to Improve Functional Outcome and Persistent Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT03261817
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders No drug interventions supportive_care Not Available terminated NCT05824117
Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education. No drug interventions treatment Not Available recruiting NCT01072617
Cerebellar rTMS for the Treatment of Schizophrenic Patients No drug interventions treatment Not Available completed NCT00283517
A Registry of Treatment Adherence for Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04481217
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia No drug interventions basic_science Not Available unknown_status NCT02442817
Linagliptin and Mesenchymal Stem Cells: A Pilot Study basic_science 4 completed NCT02110017
Exploration of Neural Bases in Social Cognition No drug interventions health_services_research Not Available unknown_status NCT04248517
Using mHealth to Optimize Pharmacotherapy Regimens No drug interventions other Not Available completed NCT00101634
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia treatment 3 completed NCT02667834
Efficiency of the French Translation Social Cognition and Interactive Training (SCIT)Program No drug interventions treatment Not Available completed NCT03451734
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients Not Available Not Available completed NCT02869334
Remediation of Auditory Recognition in Schizophrenia With tDCS No drug interventions treatment Not Available completed NCT01243034
Waist Circumference Measurements in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT01746134
The Management of Schizophrenia in Clinical Practice (MOSAIC) No drug interventions Not Available Not Available completed NCT00167934
Determining Metabolic Effects of Valproate and Antipsychotic Therapy treatment Not Available completed NCT04712734
A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia treatment 1 completed NCT00473434
An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia treatment 3 completed NCT04446234
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building treatment 4 unknown_status NCT00637234
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia treatment 2 / 3 completed NCT00439634
Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia treatment 2 terminated NCT03079024
Minnesota Community-Based Cognitive Training in Early Psychosis No drug interventions treatment Not Available completed NCT01567124
Alleviating the Metabolic Side Effects of Antipsychotic Medications treatment 4 withdrawn NCT04709224
Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia treatment 1 completed NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates treatment 4 recruiting NCT04637724
Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia No drug interventions treatment Not Available completed NCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone treatment 3 completed NCT06494124
Efficacy and Safety of tACS vs tDCS in Schizophrenia No drug interventions treatment Not Available recruiting NCT02520024
Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living No drug interventions Not Available Not Available completed NCT01213524
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia basic_science 2 completed NCT00042224
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia treatment 1 / 2 completed NCT02167724
Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or No drug interventions Not Available Not Available completed NCT01948024
Bio-equivalence Study Between SAPHRIS and Asenapine other 1 completed NCT01607424
Specific Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT01793324
EMR Data to Assess Monitoring of Patients Treated With Quetiapine No drug interventions Not Available Not Available completed NCT01268124
Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects No drug interventions treatment 1 completed NCT02458924
Niacin Skin Flush Response in Patients With Schizophrenia diagnostic 2 / 3 completed NCT01698216
Switching From Consta® to Sustenna® in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT01423916
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder treatment 1 completed NCT00490516
ACP-104 in Acutely Psychotic Subjects With Schizophrenia treatment 2 completed NCT01568216
20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms No drug interventions treatment 2 terminated NCT00261716
Motivational Interviewing to Improve Work Outcomes in Schizophrenia No drug interventions treatment 3 completed NCT00885716
A Shared Decision Making Training for Inpatients With Schizophrenia No drug interventions health_services_research Not Available unknown_status NCT00307216
Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis No drug interventions treatment Not Available completed NCT03602716
High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia No drug interventions treatment Not Available terminated NCT03822416
Treating Smokers With Mental Illness treatment 2 completed NCT04432116
Time and Virtual Reality in Schizophrenia and Bipolar Disorder No drug interventions basic_science Not Available unknown_status NCT04004416
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis basic_science 4 recruiting NCT01998516
Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder No drug interventions Not Available Not Available completed NCT02131116
Integrated Metacognitive Therapy in First Episode Psychosis No drug interventions treatment Not Available completed NCT00937716
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies No drug interventions Not Available Not Available completed NCT01563016
Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT06336616
Getting Out of the House: Using Behavioral Activation to Increase Community Participation No drug interventions supportive_care Not Available recruiting NCT04335916
Survey on Pre-ECT Evaluation and ECT Application No drug interventions Not Available Not Available unknown_status NCT03818516
Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia No drug interventions basic_science Not Available completed NCT00237796
Functional Rehabilitation of Older Patients With Schizophrenia No drug interventions treatment Not Available completed NCT01028196
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression No drug interventions Not Available Not Available completed NCT00541996
Study Comparing Bioavailability of Oral Formulations of Vabicaserin health_services_research 1 completed NCT04399096
Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experience of Hallucinations No drug interventions Not Available Not Available unknown_status NCT01142596
Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) treatment 3 completed NCT04240496
Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics No drug interventions supportive_care Not Available completed NCT01377896
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours No drug interventions Not Available Not Available completed NCT00564096
Transcranial Magnetic Stimulation (TMS) in Schizophrenia No drug interventions basic_science 2 / 3 unknown_status NCT04870996
RCT of tDCS Combined With Cognitive Training in Schizophrenia No drug interventions basic_science Not Available completed NCT01376596
Group Cognitive-behavioral Intervention for Social Anxiety in Schizophrenia No drug interventions treatment 1 / 2 completed NCT00814996
Social Functioning in Schizophrenia No drug interventions Not Available Not Available completed NCT06284096
The Personal Recovery Based Psychoeducation For Schizophrenia No drug interventions supportive_care Not Available not_yet_recruiting NCT02552758
The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism treatment Not Available unknown_status NCT00005658
Glycine to Treat Psychotic Disorders in Children treatment 2 completed NCT00154258
A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia treatment 2 completed NCT06071858
Enhanced Coordinated Specialty Care for Early Psychosis No drug interventions treatment Not Available recruiting NCT05416658
Shared Decision Making for Antipsychotic Medications No drug interventions health_services_research Not Available not_yet_recruiting NCT01125358
A Study in Schizophrenic Patients treatment 2 terminated NCT02669758
A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia No drug interventions treatment 3 completed NCT02593058
Positive Emotions Program for Schizophrenia (PEPS) No drug interventions treatment Not Available completed NCT00697658
INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia Not Available Not Available completed NCT01683058
Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia treatment 3 completed NCT01368458
Conversion to Antipsychotic Monotherapy No drug interventions treatment Not Available terminated NCT05137158
iTBS on Negative Symptoms and Cognitive Function in Schizophrenia No drug interventions treatment Not Available completed NCT01716858
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia No drug interventions treatment 2 completed NCT00231335
Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophrenia treatment 4 completed NCT02090335
Health Promotion and Fitness for Younger and Older Adults With SMI No drug interventions prevention Not Available completed NCT04553835
Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients No drug interventions treatment Not Available unknown_status NCT04655235
Translational Investigation of the Glutamatergic and GABAergic System in Schizophrenia No drug interventions Not Available Not Available not_yet_recruiting NCT04865835
A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia. treatment 1 completed NCT04176835
Oxytocin and Social Decision Making in Schizophrenia other Not Available completed NCT03959735
High Intensity Interval Training in Severe Mental Illness No drug interventions treatment Not Available completed NCT01774435
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant No drug interventions treatment 1 completed NCT00057135
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness No drug interventions treatment Not Available completed NCT00223535
Cognitive Remediation and Social Skills Training in Schizophrenia No drug interventions treatment Not Available completed NCT04975035
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine No drug interventions treatment 1 / 2 terminated NCT01793935
Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for Schizophrenia No drug interventions treatment Not Available completed NCT02237235
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia No drug interventions treatment 2 completed NCT00690235
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia other 4 completed NCT01726335
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia treatment 4 completed NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia treatment 3 recruiting NCT01175135
An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia treatment 2 completed NCT04148963
A Study of Staccato Loxapine (ADASUVE®) for Inhalation treatment 3 unknown_status NCT00570063
Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo treatment 2 terminated NCT02227563
tDCS & Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available terminated NCT01602263
Transcranial Direct Current Stimulation (tDCS) and Cognitive Processing No drug interventions Not Available Not Available completed NCT01499563
Study of a Novel Antipsychotic ITI-007 in Schizophrenia treatment 2 completed NCT02712463
A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics No drug interventions Not Available Not Available completed NCT02534363
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up treatment 4 completed NCT06345963
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) No drug interventions treatment Not Available recruiting NCT00455663
Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia No drug interventions treatment Not Available completed NCT00102063
Aripiprazole in Adolescents With Schizophrenia treatment 3 completed NCT01031563
Risk Perception in Drug-Dependent Adults With and Without Schizophrenia No drug interventions Not Available Not Available completed NCT05032963
Neurocognition After Perturbed Sleep No drug interventions basic_science Not Available completed NCT05464563
Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in Schizophrenia No drug interventions other Not Available completed NCT04511663
The Effectiveness of Assertive Community Treatment on Schizophrenic Patients No drug interventions treatment Not Available completed NCT03497663
VIA Family - Family Based Early Intervention Versus Treatment as Usual No drug interventions treatment Not Available completed NCT06155786
Cognitive Effects of tDCS and tRNS in Schizophrenia No drug interventions treatment Not Available recruiting NCT01397786
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia treatment 3 completed NCT04092686
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia treatment 3 completed NCT02532686
DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia No drug interventions treatment 2 completed NCT05413486
Sleep, Obesity and Mental Disease - Biological Markers for the Evaluation of Circadian Rhythmicity No drug interventions Not Available Not Available recruiting NCT02748486
Efficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... No drug interventions treatment Not Available completed NCT05282186
What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia No drug interventions treatment Not Available recruiting NCT00712686
Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia treatment 3 completed NCT01088386
Zyprexa® Relprevv™ Patient Care Program No drug interventions Not Available Not Available enrolling_by_invitation NCT02197286
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia treatment 2 withdrawn NCT03121586
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia treatment 3 terminated NCT06060886
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis treatment 4 not_yet_recruiting NCT03527186
Comparative Bioavailability of Risperidone treatment 1 completed NCT02614586
Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia other 1 terminated NCT03865186
An Evaluation of a Psychoeducation Program in Individuals Diagnosed With Schizophrenia No drug interventions supportive_care Not Available completed NCT00655239
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis No drug interventions prevention Not Available completed NCT00369239
Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis treatment 4 completed NCT01773239
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia No drug interventions treatment Not Available completed NCT00295139
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients No drug interventions treatment Not Available completed NCT03485339
Substance Misuse To Psychosis for Ketamine (SToP-K) No drug interventions Not Available Not Available completed NCT04278339
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder No drug interventions other Not Available recruiting NCT03382639
A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia other 2 completed NCT00169039
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia treatment 4 terminated NCT01683539
Understanding How Cognitive Remediation Works No drug interventions treatment Not Available completed NCT02337439
Perceptual Deficits in Schizophrenia No drug interventions treatment Not Available unknown_status NCT01466439
Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component No drug interventions basic_science 2 completed NCT01786239
Omega-3 Dietary Supplements in Schizophrenia treatment Not Available completed NCT01362439
Paliperidone Extended Release in Schizophrenia Participants With Duration of Illness Less Than 10 Years treatment 4 completed NCT00352339
The New Strategy for Pharmacological Treatment in People With Schizophrenia treatment 4 unknown_status NCT02884739
Mental Healthcare in Older Adults With Schizophrenia No drug interventions Not Available Not Available unknown_status NCT03873922
Ketogenic Diet for Psychotic Disorders No drug interventions treatment Not Available recruiting NCT02681822
Multi-center Imaging Genetics Studies in China No drug interventions Not Available Not Available unknown_status NCT01579422
Social Cognitive Training for Psychosis: Treatment Development No drug interventions treatment 1 completed NCT01879722
Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants treatment 1 completed NCT02787122
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT00977522
A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia treatment 2 terminated NCT00224822
The Effects of Aripiprazole on Patients With Metabolic Syndrome treatment 4 completed NCT02892422
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia No drug interventions treatment 3 completed NCT00305422
Effect of Quetiapine on Negative Symptoms and Cognition treatment 3 completed NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment No drug interventions Not Available Not Available unknown_status NCT01900522
Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia Not Available 1 terminated NCT00166322
Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects No drug interventions diagnostic Not Available completed NCT03996122
Research of Anatomo-functional Biomarkers in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02013622
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia treatment 3 completed NCT01493622
The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia treatment 4 completed NCT00239122
Recovery Therapy Trial No drug interventions treatment Not Available completed NCT00538122
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment No drug interventions Not Available Not Available completed NCT01875822
Open-label Study of Curcumin C-3 Complex in Schizophrenia No drug interventions treatment 1 / 2 completed NCT01884025
Get Moving and Get Well - Pilot Study No drug interventions treatment Not Available completed NCT05838625
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia No drug interventions treatment 3 recruiting NCT03922425
Community-based Mental Health Care for People With Severe and Enduring Mental III Health No drug interventions supportive_care Not Available unknown_status NCT05179525
Comparative Bioavailability of Risperidone. treatment 1 completed NCT00194025
Valproate in Late Life Schizophrenia treatment 4 completed NCT03510325
Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime treatment 4 unknown_status NCT03662425
Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible Mechanisms treatment Not Available completed NCT06474325
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA No drug interventions supportive_care Not Available not_yet_recruiting NCT01139125
An Open Trial of Cysteamine Treatment in Schizophrenia treatment Not Available terminated NCT03893825
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia treatment 3 completed NCT00580125
Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia treatment 2 completed NCT02918825
Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia treatment Not Available completed NCT02935725
A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy Males treatment 1 completed NCT00205725
Pfizer/IVGTT/Ziprasidone/Olanzapine treatment Not Available completed NCT03451630
PCORI Integrated Care (IC) Models for Patient-Centered Outcomes No drug interventions health_services_research Not Available active_not_recruiting NCT02717130
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol treatment Not Available terminated NCT01012830
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia treatment 4 unknown_status NCT04370730
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents No drug interventions other Not Available recruiting NCT02224430
Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body Sensors No drug interventions Not Available Not Available completed NCT00914030
Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders No drug interventions Not Available Not Available unknown_status NCT04414930
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia No drug interventions treatment 2 recruiting NCT02526030
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up treatment 4 completed NCT00448630
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics No drug interventions Not Available Not Available completed NCT01523730
Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia No drug interventions basic_science Not Available completed NCT00758030
Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults. treatment 1 completed NCT05448430
iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging. No drug interventions screening Not Available unknown_status NCT02675530
Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism Not Available 1 completed NCT05111548
Brain Stimulation and Cognitive Training - Efficacy No drug interventions treatment Not Available completed NCT01245348
Relative Effectiveness of Schizophrenia Therapy Study No drug interventions Not Available Not Available completed NCT01942148
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia treatment 3 completed NCT05899348
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders No drug interventions treatment Not Available recruiting NCT05567848
Accelerated TMS in Psychosis No drug interventions treatment 1 / 2 enrolling_by_invitation NCT01939548
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia treatment 2 terminated NCT01150448
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia treatment 1 completed NCT00085748
Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia treatment 3 completed NCT00295048
Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT02685748
Aspirin in Young Psychotic Patients treatment 2 / 3 completed NCT02622048
Understanding and Helping Families: Parents With Psychosis No drug interventions supportive_care Not Available unknown_status NCT05345548
Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives. No drug interventions diagnostic Not Available unknown_status NCT01086748
A Study in Schizophrenia Patients treatment 2 completed NCT00575848
Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia No drug interventions basic_science 1 terminated NCT06347848
The Effect of Psychoeducation Focused on Reducing Internalized Stigma No drug interventions supportive_care Not Available not_yet_recruiting NCT06197048
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder No drug interventions prevention Not Available recruiting NCT00210548
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia treatment 3 completed NCT05784948
Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis No drug interventions prevention Not Available completed NCT00946348
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment basic_science 1 completed NCT05340348
Patientheque in Patients With a Psychosis . No drug interventions basic_science Not Available recruiting NCT06486948
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment With CT-156 for People With Schizophrenia. No drug interventions basic_science Not Available active_not_recruiting NCT04068857
Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP) No drug interventions treatment Not Available withdrawn NCT03260257
A Neurofeedback Intervention to Improve Working Memory in Schizophrenia No drug interventions treatment Not Available completed NCT00161057
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment No drug interventions Not Available Not Available completed NCT04436757
Self and Body-esteem in Socio-professional Rehabilitation No drug interventions treatment Not Available unknown_status NCT03201757
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 No drug interventions treatment 3 completed NCT04210557
Models of Auditory Hallucination No drug interventions basic_science Not Available terminated NCT00508157
A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome treatment 4 terminated NCT04856657
Targeting Individual Alpha Frequencies to Enhance Perceptual Timing No drug interventions Not Available Not Available completed NCT04038957
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging treatment 1 completed NCT06572657
Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial No drug interventions treatment Not Available recruiting NCT01410357
Improving Outcomes for Individuals With Serious Mental Illness and Diabetes No drug interventions supportive_care Not Available completed NCT03730857
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics treatment 1 completed NCT03217357
tDCS, Stress and Risk for Schizophrenia No drug interventions basic_science Not Available completed NCT03075657
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia treatment 4 completed NCT02566057
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis No drug interventions treatment Not Available completed NCT03393026
A Study of Lurasidone HCl in Subjects With Schizophrenia treatment 4 completed NCT01493726
A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia treatment 1 completed NCT04143126
Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES) No drug interventions treatment Not Available recruiting NCT02202226
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia No drug interventions treatment 1 completed NCT01046526
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia No drug interventions Not Available Not Available completed NCT00330226
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders No drug interventions Not Available Not Available unknown_status NCT03601026
Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use No drug interventions prevention Not Available recruiting NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine other 4 terminated NCT02009826
Psychosis-Associated Neuroinflammation in Schizophrenia No drug interventions Not Available Not Available completed NCT00768326
Efficacy of Lu 31-130 in Patients With Schizophrenia treatment 2 completed NCT01547026
Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic Patients No drug interventions treatment Not Available completed NCT01521026
Cognitive Training for Patients With Schizophrenia No drug interventions treatment Not Available completed NCT04849026
Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18 basic_science 1 completed NCT00445926
Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in Schizophrenia No drug interventions treatment 1 completed NCT00334126
Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia No drug interventions treatment 3 completed NCT03559426
Research Into Antipsychotic Discontinuation and Reduction Trial No drug interventions treatment 4 completed NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Not Available Not Available completed NCT00981526
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia treatment 4 completed NCT04916626
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis No drug interventions treatment Not Available recruiting NCT00373126
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia treatment 4 completed NCT00400166
Recovery Guide Intervention for Recurrent Psychiatric Hospitalization No drug interventions supportive_care Not Available completed NCT04418466
Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant treatment 1 / 2 completed NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome treatment Not Available completed NCT00575666
Intranasal Insulin Treatment in Patients With Schizophrenia No drug interventions treatment 4 completed NCT01369966
Brain Circuits in Schizophrenia and Smoking No drug interventions Not Available Not Available completed NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives No drug interventions Not Available Not Available recruiting NCT04323566
Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvement treatment 2 enrolling_by_invitation NCT01412866
Electronic Decision Support Systems for Smokers With Severe Mental Illness No drug interventions treatment Not Available completed NCT06556966
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects No drug interventions treatment 1 not_yet_recruiting NCT00169065
Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia treatment 4 completed NCT01093365
Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia treatment 2 completed NCT00505765
A Multicenter Study of NAP (AL-108) in Schizophrenia treatment 2 completed NCT03663465
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics No drug interventions prevention Not Available completed NCT05109065
Peripheral Immune System in Individuals With Schizophrenia No drug interventions Not Available Not Available recruiting NCT02746965
Magnetic Seizure Therapy for Schizophrenia No drug interventions treatment Not Available terminated NCT03130465
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02756065
Connectomics in Psychiatric Classification of Bipolar Disorder and Schizophrenia No drug interventions Not Available Not Available completed NCT02896374
Normal and Abnormal ERP During ToM and Emotional Conflicts in Schizophrenia No drug interventions diagnostic Not Available completed NCT00235274
Effects of RG1068 (Secretin) on Information Processing in Schizophrenia treatment 2 completed NCT04659174
An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4) treatment 3 completed NCT03005574
Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program No drug interventions treatment Not Available completed NCT01855074
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders treatment 4 completed NCT00000374
Treatment for First-Episode Schizophrenia treatment 4 completed NCT00305474
Identification and Treatment of the Liability to Develop Schizophrenia diagnostic 4 unknown_status NCT01788774
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths treatment 1 completed NCT02034474
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia treatment 4 completed NCT03621774
Mobile CBT for Negative Symptoms No drug interventions treatment Not Available completed NCT00245674
SOLIACS: Solian Solution in the Acute Setting treatment 4 completed NCT00535574
Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia prevention 3 completed NCT03652974
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy treatment 4 completed NCT01593774
Melatonin for Prevention of Metabolic Side Effects of Olanzapine prevention 2 completed NCT00237874
Aripiprazole Treatment of Prodromal Patients treatment 2 / 3 completed NCT04874974
Feasibility of a Novel Process-based Treatment for Patients With Psychosis No drug interventions treatment Not Available completed NCT01140620
Effects of Ketamine and Risperidone on Cognition basic_science 4 completed NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder treatment 3 completed NCT01045720
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia No drug interventions treatment 2 unknown_status NCT00628420
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics Not Available 1 completed NCT01235520
A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) treatment 3 completed NCT01448720
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate treatment 3 completed NCT00783120
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Negative Symptoms in Schizophrenia No drug interventions treatment Not Available completed NCT00527020
First Time in Human Study With GSK1018921 treatment 1 completed NCT01342120
PHARMO Institute Seroquel Safety Study No drug interventions Not Available Not Available completed NCT03995420
VR Therapy for Psychosis Negative Symptoms (V-NeST) No drug interventions treatment Not Available unknown_status NCT03522220
Augmentation of Neuronal Network Plasticity in Schizophrenia No drug interventions basic_science Not Available unknown_status NCT01258920
A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia treatment 3 completed NCT06573320
Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine No drug interventions treatment Not Available recruiting NCT03974620
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia No drug interventions treatment Not Available not_yet_recruiting NCT00137020
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder treatment 4 completed NCT00465920
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis No drug interventions treatment 2 unknown_status NCT00412620
An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia No drug interventions treatment 2 terminated NCT02167620
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness treatment 4 completed NCT00982020
Study in Adolescents With Schizophrenia or Bipolar Disorder treatment 4 completed NCT02713282
A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation treatment 3 completed NCT01320982
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder treatment 3 unknown_status NCT01129882
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia treatment 3 completed NCT02033382
Biomarkers in First Episode Schizophrenia No drug interventions Not Available Not Available completed NCT00192582
AIMHI NT Relapse Prevention Trial No drug interventions Not Available Not Available unknown_status NCT01942382
A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia treatment 1 completed NCT02969382
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia treatment 2 completed NCT02874482
Cognitive and Emotional Factors in Visual Exploration Among Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00265382
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia treatment 3 terminated NCT03418831
Adjunctive Selective Estrogen Receptor Modulators on Negative and Cognitive Symptoms of Schizophrenia in Women treatment 4 completed NCT03967431
Effects of Narrative Enhancement and Cognitive Therapy (NECT) on Self-stigma in Patients With Schizophrenia No drug interventions other Not Available completed NCT00809731
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment No drug interventions Not Available Not Available completed NCT03485131
Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations No drug interventions treatment Not Available completed NCT01685931
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics treatment 4 completed NCT01828931
Lifestyle Intervention for Diabetes and Weight Management in Psychosis No drug interventions treatment Not Available completed NCT02341131
Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels No drug interventions treatment Not Available completed NCT00161031
Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia treatment Not Available completed NCT04798131
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations No drug interventions treatment Not Available not_yet_recruiting NCT03859973
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia treatment 2 completed NCT01971073
Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia No drug interventions treatment Not Available terminated NCT03892473
Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E ) No drug interventions health_services_research Not Available unknown_status NCT00505973
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects No drug interventions treatment 1 completed NCT01324973
Web-Based Weight Management for Individuals With Mental Illness No drug interventions treatment Not Available completed NCT02874573
Tocilizumab in Schizophrenia treatment 1 recruiting NCT00418873
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward treatment 4 terminated NCT03476473
Early Detection of Respiratory Disorders in Psychosis No drug interventions Not Available Not Available unknown_status NCT01994473
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia treatment 1 completed NCT05838573
Metformin Treatment on Cognitive Impairment of Schizophrenia treatment 3 recruiting NCT01309373
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT04054973
L-arginine Study for Persistent Symptoms of Schizophrenia treatment 2 withdrawn NCT01074073
Lithium Drug-Drug Interaction Study With Lurasidone HCl Not Available 1 completed NCT01634373
Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Not Available 1 completed NCT01182727
Salsalate for Insulin Resistance in Schizophrenia treatment Not Available completed NCT00366327
Study Evaluating Bifeprunox in Patients With Schizophrenia. treatment 3 terminated NCT00314327
Optimizing Response in Psychosis Study treatment 4 terminated NCT00797927
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia treatment 4 completed NCT00103727
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia treatment 2 completed NCT03774927
High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients No drug interventions treatment Not Available completed NCT03880227
Improving Visual Attention in Schizophrenia No drug interventions basic_science Not Available completed NCT04118127
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses No drug interventions treatment 1 completed NCT00080327
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia treatment 4 completed NCT05342727
Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia No drug interventions basic_science 1 completed NCT00838227
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder treatment 2 withdrawn NCT02478827
A Trial of Cognitive Training in Schizophrenia No drug interventions supportive_care Not Available completed NCT01913327
Antipsychotic Effects on Brain Function in Schizophrenia treatment 4 terminated NCT05956327
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training No drug interventions supportive_care Not Available recruiting NCT00505076
Treatment Study for Cognitive Deficits in Schizophrenia treatment 2 completed NCT01927276
Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive No drug interventions other Not Available completed NCT00216476
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT00654576
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia treatment 4 completed NCT00224276
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics No drug interventions Not Available Not Available completed NCT03892876
Trial of Stimulus-response Potentiation in Schizophrenia No drug interventions treatment Not Available completed NCT02926976
The Optimal Treatment for Treatment-resistant Schizophrenia treatment Not Available unknown_status NCT03576976
Improving Accessibility and Personalization of CR for Schizophrenia No drug interventions treatment Not Available completed NCT00796276
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone treatment 1 completed NCT01376076
Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia treatment 1 completed NCT03164876
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers. treatment 1 completed NCT00100776
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT00924976
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families No drug interventions health_services_research Not Available completed NCT02864576
Cognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment No drug interventions treatment Not Available completed NCT02535676
Schizophrenia TreAtment With electRic Transcranial Stimulation No drug interventions treatment 3 completed NCT00205660
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole No drug interventions treatment 4 completed NCT04187560
Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults treatment 1 completed NCT00001260
Brain Tissue Collection for Neuropathological Studies No drug interventions Not Available Not Available terminated NCT01577160
A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia treatment 4 completed NCT01620060
Lurasidone Pediatric Pharmacokinetics Study treatment 1 completed NCT00533260
A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) No drug interventions Not Available Not Available completed NCT05951660
Sex, Psychopharmacology, and Diabetes No drug interventions supportive_care Not Available recruiting NCT04825860
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase treatment 2 / 3 terminated NCT01009060
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia treatment 2 completed NCT00712660
Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia No drug interventions prevention Not Available completed NCT00759460
Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia treatment 3 completed NCT00430560
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia No drug interventions treatment 2 / 3 completed NCT01412060
A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia prevention 3 completed NCT05517460
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center No drug interventions supportive_care Not Available completed NCT00940394
Effectiveness of Family Group Interventions for People With Schizophrenia No drug interventions health_services_research 2 completed NCT00136994
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) treatment 3 completed NCT02570594
Autobiographical Memory Organization in Schizophrenia No drug interventions diagnostic Not Available completed NCT05119894
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia treatment 1 withdrawn NCT02863094
Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory Hallucinations No drug interventions treatment Not Available completed NCT00182494
Diabetes Prevention Program in Schizophrenia [DPPS] No drug interventions prevention 4 unknown_status NCT03693794
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics No drug interventions Not Available Not Available unknown_status NCT00261794
Cognitive Remediation for Schizophrenia No drug interventions treatment Not Available completed NCT04005794
Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive Training No drug interventions basic_science Not Available recruiting NCT00246194
Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) Not Available Not Available completed NCT00105794
Psychiatric Advance Directives for Improved Mental Health Care No drug interventions treatment Not Available completed NCT01518894
A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia basic_science 1 completed NCT05746494
The Efficacy of Neural Stimulation in Individuals With Schizophrenia No drug interventions basic_science Not Available active_not_recruiting NCT00231894
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia treatment 4 completed NCT02748694
Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study No drug interventions other 1 completed NCT03919994
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) No drug interventions Not Available Not Available completed NCT00222794
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia treatment 4 completed NCT04545294
Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of Schizophrenia No drug interventions treatment Not Available completed NCT05664594
State Representation in Early Psychosis - Project 4 No drug interventions basic_science Not Available recruiting NCT00957294
Metabolic Syndrome in Patients With First-episode Schizophrenia No drug interventions Not Available Not Available completed NCT01165294
The Effect of Ketamine on Attentiveness basic_science 1 completed NCT00113594
Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder treatment 3 completed NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents treatment 4 recruiting NCT01370291
Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients No drug interventions treatment 3 unknown_status NCT02782091
Discriminant Validity of the Multiple Errands Test in Schizophrenia No drug interventions diagnostic Not Available completed NCT02532491
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up treatment 4 unknown_status NCT00430391
Comparison of Video Consent Versus Routine Consent for Participation in Research Studies No drug interventions Not Available Not Available completed NCT03346291
Examining Persistence in Smokers With Schizophrenia No drug interventions treatment Not Available completed NCT01401491
Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine treatment 4 completed NCT02670291
Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation No drug interventions treatment Not Available completed NCT00210691
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder treatment 3 completed NCT02006862
eVAluatIon of OLanzapine TreatmEnT No drug interventions Not Available Not Available completed NCT00312962
Effectiveness of Targeted Cognitive Training for Neurological Deficits in People With Schizophrenia No drug interventions treatment 1 / 2 completed NCT00211562
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids prevention 3 terminated NCT02022462
Project Bridge: Peer Health Navigator Intervention No drug interventions treatment Not Available completed NCT02210962
Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia No drug interventions prevention 4 unknown_status NCT00179062
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder treatment Not Available completed NCT00921362
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme No drug interventions Not Available Not Available completed NCT02281162
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain No drug interventions Not Available Not Available completed NCT02704962
Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine treatment 4 completed NCT06442462
Study of SPG302 in Adults With Schizophrenia treatment 2 recruiting NCT01655680
A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia treatment 2 completed NCT00137280
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) No drug interventions health_services_research Not Available completed NCT01810380
Brexpiprazole in Patients With Acute Schizophrenia treatment 3 completed NCT00177580
Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin treatment 4 completed NCT05582980
Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia No drug interventions treatment Not Available recruiting NCT01289080
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects treatment 1 completed NCT05304780
Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia No drug interventions supportive_care Not Available completed NCT01263080
Evaluation of Mirtazapine and Folic Acid for Schizophrenia: treatment 4 completed NCT02334280
Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI No drug interventions health_services_research Not Available completed NCT01192880
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia treatment 3 completed NCT00004980
Repetitive Transcranial Magnetic Stimulation for "Voices" No drug interventions treatment 2 completed NCT02765880
Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders No drug interventions other Not Available recruiting NCT00645580
Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function treatment Not Available unknown_status NCT04011280
Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness treatment 4 completed NCT00216580
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis treatment 3 completed NCT00211380
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) treatment Not Available terminated NCT02349880
A Shared Decision-making Training for Inpatients With Schizophrenia No drug interventions health_services_research Not Available completed NCT02131129
rTMS in First Episode Psychosis No drug interventions treatment Not Available completed NCT00364429
SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia diagnostic 1 terminated NCT01154829
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS) diagnostic Not Available completed NCT05282329
Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia No drug interventions treatment Not Available completed NCT01078129
Cognitive Remediation Therapy and Schizophrenia No drug interventions supportive_care Not Available completed NCT00650429
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT02642029
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study No drug interventions basic_science Not Available completed NCT01568229
20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) No drug interventions treatment 2 terminated NCT01542229
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness) No drug interventions health_services_research Not Available completed NCT01911429
Pediatric Schizophrenia Efficacy and Safety Study treatment 3 completed NCT00681629
Schizophrenic Patients in Integrated Care treatment 4 terminated NCT01488929
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia treatment 2 completed NCT01696929
An Open-Label Trial of Tocilizumab in Schizophrenia treatment 1 completed NCT02232529
Pharmacokinetic Study of MIN-101 in Healthy Subjects basic_science 1 completed NCT03314129
Remediation of Visual Perceptual Impairments in People With Schizophrenia No drug interventions treatment Not Available active_not_recruiting NCT03558529
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse No drug interventions Not Available Not Available completed NCT00796029
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose treatment 1 completed NCT01794429
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue treatment 3 completed NCT00173329
The Quality of Life of Patients With Severe Illnesses No drug interventions Not Available Not Available unknown_status NCT02019329
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone treatment 1 completed NCT02077829
Implementation of Illness Management and Recovery in Mental Health Services No drug interventions health_services_research Not Available completed NCT00645229
A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder treatment 3 terminated NCT00761189
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia treatment 4 completed NCT02469389
Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia No drug interventions treatment Not Available completed NCT02326389
Exercise and Cognitive Training No drug interventions treatment Not Available completed NCT01082289
Digoxin Drug-Drug Interaction With Lurasidone HCl Not Available 1 completed NCT06356389
A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. No drug interventions treatment 1 / 2 completed NCT00325689
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder. treatment 4 completed NCT05698589
COMpassion for Psychiatric Disorders And Self-Stigma No drug interventions treatment Not Available recruiting NCT01689389
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study No drug interventions Not Available Not Available completed NCT01170689
The Prevalence of Obesity For Schizophrenia Inpatients in Taiwan No drug interventions Not Available Not Available completed NCT03469089
Touchscreen-based Cognitive Tests in Healthy Volunteers basic_science 1 unknown_status NCT00174889
Pregnenolone in the Management of Schizophrenia Patients treatment 1 completed NCT01760889
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia treatment 3 terminated NCT03892889
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® health_services_research 3 terminated NCT05065489
Resting State Electroencephalogram for Psychotic Disorders No drug interventions Not Available Not Available active_not_recruiting NCT00320489
Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia treatment 3 completed NCT01398189
F-18 Altanserin PET Study of Patients Receiving Clozapine basic_science Not Available unknown_status NCT00111189
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. prevention 3 completed NCT00061789
Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia treatment 2 completed NCT02398292
A Multi-modal Approach to Addressing Cardiovascular Risk and Building Resilience in Youths With Psychosis No drug interventions treatment Not Available completed NCT01364792
To Rescue Cognition With Valaciclovir treatment 2 completed NCT01041092
Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women treatment 4 completed NCT00257192
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia treatment 3 terminated NCT01376492
FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain No drug interventions Not Available Not Available completed NCT00790192
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. treatment 3 completed NCT04887792
Acetazolamide for Treatment Resistant Schizophrenia treatment 1 / 2 recruiting NCT00001192
Neuropsychological Evaluation of Psychiatric and Neurological Patients No drug interventions Not Available Not Available completed NCT02069392
Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia treatment Not Available completed NCT01104792
Long-term Study of Cariprazine in Patients With Schizophrenia treatment 3 completed NCT05480592
A Study of HS-10380 in Chinese Participants No drug interventions treatment 1 recruiting NCT02885792
Coronary Artery Disease in Patients Suffering From Schizophrenia No drug interventions prevention Not Available unknown_status NCT00446992
Diabetes in Neuropsychiatric Disorders treatment 1 / 2 completed NCT05206292
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders. No drug interventions diagnostic Not Available recruiting NCT02008292
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors other Not Available completed NCT00140192
Creatine Treatment in Psychiatric Disorders prevention 3 completed NCT01908192
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® No drug interventions treatment 2 / 3 terminated NCT05739344
The Effect of Developing Psychological Resilience on Functionality in Schizophrenia Patients No drug interventions supportive_care Not Available completed NCT00480844
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone treatment 4 unknown_status NCT00044044
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia treatment 2 completed NCT00770744
Efficacy of Lu 31-130 in Patients With Schizophrenia treatment 2 completed NCT00001544
Genetic Aspects of Neurologic and Psychiatric Disorders No drug interventions Not Available Not Available completed NCT02796144
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia treatment 4 terminated NCT04740944
Salutogenic Approach Based Interview With People With Schizophrenia No drug interventions health_services_research Not Available completed NCT02183844
A System for Preference Assessment in Mental Health No drug interventions health_services_research Not Available completed NCT02079844
Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia treatment 1 completed NCT00645944
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia treatment Not Available completed NCT03223844
Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release basic_science Not Available unknown_status NCT00499044
A Comparison of Two Cognitive Batteries in People With Schizophrenia No drug interventions Not Available Not Available completed NCT03351244
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months treatment 2 terminated NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs treatment 3 completed NCT04038840
Imaging Synapses With [11C] UCB-J in the Human Brain No drug interventions other 1 recruiting NCT00199940
Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness treatment 4 completed NCT00686140
A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia treatment Not Available completed NCT00791440
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy No drug interventions treatment Not Available completed NCT01429740
A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults basic_science 1 completed NCT06326840
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment treatment Not Available completed NCT00827840
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia treatment 4 completed NCT03370640
Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2). treatment 1 completed NCT04068467
Evaluation of mHealth for Serious Mental Illness No drug interventions supportive_care Not Available completed NCT01967667
Biological Evaluation of Dietary Supplement Liposomal Glutathione No drug interventions other Not Available completed NCT01192867
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310) treatment 3 completed NCT00509067
Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia treatment 2 completed NCT01029067
Metacognitive Training in Schizophrenia No drug interventions treatment Not Available completed NCT04280367
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age No drug interventions Not Available Not Available completed NCT00810667
Efficacy Study Exploring the Effect of Lu AE58054 as Augmentation Therapy in Patients With Schizophrenia treatment 2 completed NCT01490567
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia treatment 4 unknown_status NCT00137267
A Brief Community Linkage Intervention for Dually Diagnosed Individuals No drug interventions prevention Not Available completed NCT01125267
Promoting Adherence to Treatment in Schizophrenia No drug interventions treatment Not Available completed NCT01546467
Cognitive Remediation in Early Phase Psychosis No drug interventions treatment Not Available unknown_status NCT02512367
Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia. No drug interventions other Not Available terminated NCT04158167
Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study other Not Available completed NCT02758067
Comparison of the Effectiveness of Brexpiprazole With That of Risperidone treatment 3 withdrawn NCT02897167
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients No drug interventions Not Available Not Available completed NCT02620267
Target Engagement of the Early Auditory Processing Network by Transcranial Direct Current Stimulation (tDCS) No drug interventions device_feasibility Not Available completed NCT01012167
Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia treatment 2 completed NCT00485901
Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia treatment 3 completed NCT00155701
Mutation Screening and Translocation Detection of DISC1 Gene in Schizophrenia No drug interventions Not Available Not Available completed NCT00409201
Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia treatment 1 unknown_status NCT02159001
Electroconvulsive Therapy in Clozapine-resistant Schizophrenia No drug interventions treatment Not Available unknown_status NCT00686101
Knowledge and Perception of Smoking Risks/Consequences No drug interventions Not Available Not Available completed NCT01011101
Internal Monitoring of Eye Movement in Schizophrenia No drug interventions Not Available Not Available terminated NCT02573701
Guideline vs Usual Treatment in Schizophrenic Adolescents treatment Not Available completed NCT03699501
Psychometric Validation of an Oral Health-related Scale for Quality of Life and Coping in People With Schizophrenia No drug interventions Not Available Not Available completed NCT00791401
A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function treatment 1 completed NCT05809401
Pragmatic Assessment and Treatment for the Health System No drug interventions treatment Not Available recruiting NCT02832401
The Impact of Caffeine on Cognition in Schizophrenia basic_science Not Available completed NCT00034801
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia treatment 4 completed NCT01394601
A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia No drug interventions Not Available Not Available completed NCT00014001
CATIE- Schizophrenia Trial treatment 4 completed NCT00156104
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) treatment 3 completed NCT04296604
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations No drug interventions treatment Not Available recruiting NCT04190004
Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia other Not Available completed NCT00071604
Medication Adherence in Older People With Psychosis No drug interventions Not Available Not Available unknown_status NCT00569504
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics No drug interventions Not Available Not Available unknown_status NCT04767204
The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation Program No drug interventions health_services_research Not Available completed NCT01964404
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment? basic_science 1 completed NCT05115604
Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational Intervention No drug interventions treatment Not Available completed NCT02199704
Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series No drug interventions Not Available Not Available completed NCT02882204
Tracking Outcomes in Psychosis No drug interventions Not Available Not Available unknown_status NCT00595504
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia treatment 4 completed NCT00876304
Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia No drug interventions basic_science 1 completed NCT00525304
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition No drug interventions supportive_care Not Available completed NCT02220504
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals No drug interventions treatment Not Available completed NCT00845572
The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center No drug interventions treatment Not Available completed NCT01729572
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients No drug interventions treatment Not Available unknown_status NCT04986072
Sodium Nitroprusside in Early Course Schizophrenia treatment 2 terminated NCT06315972
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity treatment 2 not_yet_recruiting NCT00463372
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia treatment 1 completed NCT04173572
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial No drug interventions treatment Not Available completed NCT00559572
Effects of Motivating People With Schizophrenia to Exercise No drug interventions treatment Not Available completed NCT01136772
A Comparison of Long-acting Injectable Medications for Schizophrenia treatment 4 completed NCT01639872
Clozapine for Cannabis Use in Schizophrenia treatment 4 completed NCT00373672
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT01552772
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole treatment 1 completed NCT01295372
Safety and Efficacy of Zicronapine in Patients With Schizophrenia treatment 3 completed NCT05109572
The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health Center No drug interventions Not Available Not Available completed NCT01570972
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis No drug interventions treatment Not Available completed NCT03995368
Neuroplasticity in TBI and Schizophrenia No drug interventions basic_science Not Available completed NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics No drug interventions treatment Not Available completed NCT05352568
Is Cognitive Training an Option? No drug interventions treatment Not Available completed NCT04521868
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients treatment 2 completed NCT01764568
Contrasting Group Therapy Methods for Psychosis No drug interventions treatment Not Available terminated NCT03197168
Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in Chile No drug interventions health_services_research Not Available completed NCT01036568
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia No drug interventions Not Available Not Available completed NCT00018668
Antipsychotic Response in Schizophrenia treatment 4 completed NCT03565068
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) treatment 1 completed NCT00208169
Abilify Therapy for Reducing Comorbid Substance Abuse treatment 4 completed NCT00838669
A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone treatment 1 completed NCT00173069
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) No drug interventions Not Available Not Available unknown_status NCT00264069
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry No drug interventions Not Available Not Available completed NCT03317769
Creating Live Interactions to Mitigate Barriers No drug interventions treatment Not Available completed NCT01081769
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics treatment 3 completed NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia treatment Not Available completed NCT04352569
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available recruiting NCT00642369
A 4-week, Randomized, Rater-blinded, Parallel Study to Evaluate Quetiapine in Improving Sleep Quality of Schizophrenia treatment Not Available completed NCT03153046
The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis No drug interventions other Not Available completed NCT04306146
Study of CAD-9303 in Subjects With Schizophrenia No drug interventions treatment 1 completed NCT02240446
Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients No drug interventions treatment Not Available withdrawn NCT01712646
Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia treatment 1 / 2 terminated NCT02449746
Study of Immunotherapy in Autoantibody Positive Psychosis other Not Available completed NCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography No drug interventions Not Available Not Available not_yet_recruiting NCT00419146
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants treatment 2 / 3 completed NCT06041646
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder treatment 4 completed NCT04300946
Time Prediction and Cerebellum: Magnetic Transcranial Stimulation (TMS) in Healthy Volunteers No drug interventions Not Available Not Available recruiting NCT00049946
Schizophrenia Study In Adults treatment 2 completed NCT06066112
Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body treatment 1 recruiting NCT05486312
7-week Study With CT-155 in People With Schizophrenia No drug interventions treatment Not Available completed NCT00090012
Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT03466112
Aerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute Schizophrenia No drug interventions other Not Available completed NCT04276012
Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA) No drug interventions treatment Not Available unknown_status NCT01926912
A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital Setting No drug interventions Not Available Not Available completed NCT01182012
Reduction of Cardiovascular Risk in Severe Mental Illness No drug interventions prevention 4 unknown_status NCT06229210
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder treatment 3 recruiting NCT00485810
Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia treatment 1 / 2 completed NCT01592110
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia treatment 1 completed NCT02174510
A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects basic_science 1 completed NCT00640510
A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia treatment 3 completed NCT00253110
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder treatment 4 completed NCT00736710
rTMS Effects on Smoking Cessation and Cognition in Schizophrenia No drug interventions treatment Not Available completed NCT01662310
An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia treatment 3 completed NCT03434210
The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT02746510
Validation of a Clinical Screening Grid for Syndromic Schizophrenia No drug interventions diagnostic Not Available unknown_status NCT05724810
Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia No drug interventions treatment Not Available recruiting NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study No drug interventions Not Available Not Available completed NCT00567710
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study treatment 2 completed NCT03189810
Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia No drug interventions treatment Not Available completed NCT00167310
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation treatment 2 completed NCT00329810
Effect on Cognitive Function of a Treatment With Aripiprazole treatment 4 completed NCT00331981
Amisulpride in Schizophrenic Patients treatment 4 completed NCT01860781
The Effect of Paliperidone Palmitate in Schizophrenia treatment 4 completed NCT02164981
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia treatment 2 completed NCT00646581
Effect of Single Dose Intranasal Insulin On Cognitive Function treatment 4 completed NCT01083381
Is MS14 Helpful in Schizophrenia? treatment 2 unknown_status NCT03649581
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders No drug interventions treatment Not Available recruiting NCT00315081
Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine No drug interventions treatment 3 unknown_status NCT01001481
Schizophrenia Treatment Adherence Investigation (STAI) No drug interventions Not Available Not Available completed NCT01689181
Apathy in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT02037581
Integrated Care Including Assertive Community Treatment in Early Psychosis No drug interventions treatment Not Available completed NCT02538081
Nicotinic Receptors and Schizophrenia treatment 1 / 2 withdrawn NCT00942981
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography No drug interventions Not Available Not Available recruiting NCT04055181
Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders No drug interventions treatment Not Available completed NCT00970281
A Study of Olanzapine in Patients With Schizophrenia treatment 3 completed NCT01474395
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia treatment 2 unknown_status NCT02411695
Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia treatment 1 completed NCT02717195
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia treatment 3 completed NCT03360695
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer No drug interventions supportive_care Not Available completed NCT01248195
Optimization of Treatment and Management of Schizophrenia in Europe treatment 4 completed NCT00500695
Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness No drug interventions treatment 1 completed NCT02880995
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis treatment Not Available unknown_status NCT00006195
Glucose Regulation During Risperidone and Olanzapine Treatment treatment Not Available unknown_status NCT03627195
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia treatment 1 completed NCT03758495
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression No drug interventions Not Available Not Available withdrawn NCT00189995
Clozapine IM and Aggression in Schizophrenic Patients treatment 3 withdrawn NCT00605995
Add-on Simvastatin in Schizophrenia Trial treatment Not Available terminated NCT04990414
Cognitive Behaviour Therapy for Voices and Dissociation No drug interventions treatment 2 completed NCT00077714
Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia treatment 3 completed NCT00396214
Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients treatment 3 terminated NCT00220714
PREvent First Episode Relapse (PREFER) No drug interventions treatment 4 unknown_status NCT01207414
Switching to Iloperidone From Other Antipsychotics in Schizophrenia treatment 4 completed NCT01044914
Genes, Intermediate Phenotypes and Response to Quetiapine RX No drug interventions Not Available Not Available completed NCT01769014
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder No drug interventions Not Available Not Available unknown_status NCT01555814
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen diagnostic Not Available completed NCT03695614
Cognitive Remediation Therapy for Participants With Late-Life Schizophrenia No drug interventions treatment Not Available completed NCT03271814
Brain Biomarker on Inflammation Response No drug interventions basic_science 1 withdrawn NCT05731414
Outcomes From Remediation and Behavioural Intervention Techniques No drug interventions treatment Not Available recruiting NCT00132314
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia treatment 3 completed NCT04237155
French Source-monitoring Task No drug interventions other Not Available unknown_status NCT05746455
Motivation Skills Training for Schizophrenia No drug interventions treatment Not Available completed NCT04013555
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia other 1 / 2 recruiting NCT01813955
Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia health_services_research 0 terminated NCT02469155
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment treatment 3 completed NCT00304655
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) treatment 4 completed NCT00725855
A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients treatment 2 unknown_status NCT05310955
Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of Schizophrenia No drug interventions treatment Not Available unknown_status NCT00929955
Role of Anti-Inflammatory Agents in Patients With Schizophrenia treatment 1 completed NCT01433055
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients treatment Not Available completed NCT01149655
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia treatment 3 completed NCT00716755
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia. treatment Not Available completed NCT01251055
GlyT-1 Inhibitor Treatment for Refractory Schizophrenia No drug interventions treatment 2 completed NCT02824055
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics No drug interventions treatment 1 completed NCT01880255
rTMS for Working Memory Deficits in Schizophrenia No drug interventions treatment Not Available completed NCT00337350
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment prevention 4 completed NCT00047450
Antidepressant Treatment in Older Adults With Schizophrenia treatment Not Available completed NCT02011750
Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia treatment 4 completed NCT03921450
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) No drug interventions treatment Not Available completed NCT01658150
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder supportive_care Not Available completed NCT04298450
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention No drug interventions health_services_research Not Available recruiting NCT05598450
rTMS for Auditory Hallucinations Guided by Magnetoencephalography No drug interventions treatment Not Available recruiting NCT00428350
Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic treatment 4 completed NCT01043250
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients No drug interventions Not Available Not Available completed NCT03675750
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism No drug interventions Not Available Not Available unknown_status NCT05276050
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3) No drug interventions treatment Not Available recruiting NCT01399450
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients treatment 4 completed NCT00375050
Treatment of Refractory Schizophrenia With Riluzole treatment Not Available completed NCT00216723
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder Not Available Not Available completed NCT02192723
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia treatment Not Available completed NCT04738123
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) treatment 3 completed NCT05919823
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia treatment 3 recruiting NCT00176423
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia treatment 4 completed NCT02755623
Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations No drug interventions treatment Not Available recruiting NCT02409823
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics No drug interventions Not Available Not Available completed NCT00249223
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia treatment 3 completed NCT02149823
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations basic_science 1 terminated NCT00257023
An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia treatment 2 completed NCT00838123
Cognitive Functioning Related to Job Tenure Among Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00320723
Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia treatment 4 completed NCT01494623
The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory No drug interventions treatment Not Available completed NCT02305823
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis treatment 4 completed NCT01934023
Effects of Varenicline on Plasticity in Schizophrenia Not Available 2 completed NCT00001323
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia No drug interventions Not Available Not Available completed NCT04123223
Comparing Cognitive Remediation Approaches for Schizophrenia No drug interventions treatment Not Available unknown_status NCT01515423
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia No drug interventions treatment 3 completed NCT00514423
How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs No drug interventions prevention Not Available completed NCT00518323
A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients treatment 3 completed NCT00205608
Microglia Activation in Schizophrenia No drug interventions diagnostic 1 completed NCT02873208
A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia No drug interventions treatment 3 completed NCT05954208
Vısual Arts Group Therapy Based On Watson's Human Care Model In Indıvıduals Wıth Schızophrenıa No drug interventions supportive_care Not Available completed NCT00934908
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine No drug interventions prevention Not Available withdrawn NCT02878408
Immuno-Genetic, Inflammation, Retro-Virus, Environment No drug interventions basic_science Not Available recruiting NCT00294008
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR) Not Available Not Available completed NCT00177008
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety treatment 4 completed NCT00240708
A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia treatment 3 completed NCT00695708
Training-induced Cerebral Reorganization in Schizophrenia No drug interventions Not Available Not Available completed NCT02773108
Somatic Comorbidities in Psychiatric Patients No drug interventions Not Available Not Available completed NCT02834208
Emotion Endophenotypes in Schizophrenia No drug interventions Not Available Not Available unknown_status NCT00763438
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia treatment 4 completed NCT00166738
Analysis of Genomic DNA Alterations in Familial Schizophrenia No drug interventions Not Available Not Available unknown_status NCT01834638
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680) treatment 2 terminated NCT03802838
Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia treatment 4 unknown_status NCT02203838
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia treatment 3 completed NCT03896438
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2 No drug interventions treatment Not Available active_not_recruiting NCT00784238
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants treatment 4 completed NCT00316238
A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia treatment 2 completed NCT01885338
N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia treatment 1 completed NCT03915938
Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain treatment 2 / 3 completed NCT03220438
TMS Enhancement of Visual Plasticity in Schizophrenia No drug interventions basic_science Not Available terminated NCT05491538
Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness No drug interventions treatment Not Available recruiting NCT05213143
The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine treatment 4 terminated NCT04745143
Monotherapy of an NMDA Enhancer for Schizophrenia No drug interventions treatment 2 recruiting NCT02743143
Long-Term Exercise Training Therapy Versus Usual Care in Patients With Schizophrenia No drug interventions prevention Not Available completed NCT00392743
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients No drug interventions Not Available Not Available completed NCT01185743
Antipsychotics and Gene Expression in Soft Tissues basic_science 4 completed NCT00423943
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia treatment 4 completed NCT01674543
Clinical Symptoms of Schizophrenia and Physical Exercise No drug interventions treatment Not Available completed NCT02921243
Schizophrenia and the Gut Microbiome No drug interventions Not Available Not Available completed NCT04327843
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY) treatment 3 completed NCT03007303
The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients Not Available Not Available unknown_status NCT05227703
A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia treatment 2 active_not_recruiting NCT04267003
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia No drug interventions basic_science Not Available recruiting NCT01066403
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia basic_science Not Available completed NCT00945503
Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time. No drug interventions treatment 1 completed NCT00316303
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder treatment 2 completed NCT01378403
Evaluation of Dorsal Visual Stream in Patients With Schizophrenia No drug interventions Not Available Not Available completed NCT00727103
Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia treatment 4 completed NCT01595503
Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia No drug interventions treatment Not Available terminated NCT01052103
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms treatment 2 completed NCT03537703
Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia No drug interventions basic_science Not Available completed NCT02181803
MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003) treatment 1 completed NCT01851603
Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects No drug interventions treatment 1 terminated NCT01947803
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia treatment 4 completed NCT00567203
A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia No drug interventions treatment 1 completed NCT00546403
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia treatment Not Available completed NCT00669903
Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia treatment 2 terminated NCT04312503
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia" Not Available Not Available completed NCT02062190
Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia prevention 2 completed NCT05262790
The Difference of Grey Matter Volume Among the Patients of Schizophrenia No drug interventions Not Available Not Available completed NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial treatment 4 recruiting NCT00628290
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis treatment 2 completed NCT05748990
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia basic_science Not Available recruiting NCT05227690
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia treatment 2 active_not_recruiting NCT01512290
Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations No drug interventions treatment Not Available completed NCT01496690
Pregablin for Anxiety-comorbidity in Patients With Schizophrenia treatment 4 completed NCT03090490
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals No drug interventions treatment Not Available unknown_status NCT05964790
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia No drug interventions treatment 1 / 2 not_yet_recruiting NCT03093064
Inflammatory Response In Schizophrenia basic_science 1 completed NCT05273164
State Representation in Early Psychosis No drug interventions basic_science Not Available recruiting NCT00672464
Cardio Risk of Acute Schizophrenia Olanzapine Duke prevention 4 withdrawn NCT03316664
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis No drug interventions treatment Not Available completed NCT03775564
Effectiveness of the RemedRugby Program No drug interventions treatment Not Available completed NCT01300364
Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia treatment 4 unknown_status NCT02413164
Multimodal Physical Therapy Program in Schizophrenia No drug interventions treatment Not Available completed NCT00073164
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia treatment 2 completed NCT00469664
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia treatment 4 unknown_status NCT06502964
Study of ALTO-101 in Patients With Schizophrenia No drug interventions treatment 2 recruiting NCT00148564
Energy Homeostasis Under Treatment With Atypical Antipsychotics treatment 4 completed NCT00711464
Modafinil Effects on Cognition in Schizophrenia Patients treatment 4 completed NCT06107764
Cerebellar Modulation of Cognition in Psychosis No drug interventions other Not Available recruiting NCT01101464
A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) basic_science 2 completed NCT00269464
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype? No drug interventions Not Available Not Available completed NCT02188121
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients treatment 4 completed NCT01176721
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia No drug interventions treatment 2 completed NCT00001921
Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings No drug interventions Not Available Not Available completed NCT00759421
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia treatment 3 completed NCT02916121
Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia No drug interventions treatment Not Available unknown_status NCT05208021
The Effect of Psychoeducation Program on Healthy Living Behaviors No drug interventions prevention Not Available unknown_status NCT05978921
Physical Exercise in Patients With Schizophrenia No drug interventions health_services_research Not Available not_yet_recruiting NCT04554121
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing No drug interventions treatment Not Available enrolling_by_invitation NCT02639702
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia treatment 4 recruiting NCT04787302
PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing basic_science 1 completed NCT05716802
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia No drug interventions treatment Not Available completed NCT02431702
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform treatment 3 completed NCT04025502
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects No drug interventions Not Available Not Available completed NCT00645502
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. treatment 1 completed NCT02400502
Integrated Coping and Awareness Training No drug interventions treatment Not Available completed NCT02054702
Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia treatment 3 completed NCT00206102
A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT05321602
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder treatment 1 completed NCT00225602
Assertive Community Treatment in Copenhagen No drug interventions treatment Not Available unknown_status NCT00111202
Schizophrenia and Genetic Counseling No drug interventions Not Available Not Available unknown_status NCT02968602
Minocycline and Tobacco Craving in Smokers With Schizophrenia other 4 completed NCT00303602
Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height) treatment 4 completed NCT01422902
Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults No drug interventions treatment 2 completed NCT01975584
Neuroendocrine and Immune Response to Stress in Schizophrenia No drug interventions other Not Available completed NCT00212784
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) treatment 3 completed NCT02634684
Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia. treatment 2 completed NCT02205684
Effects of Physical Activity in Psychosis No drug interventions treatment Not Available unknown_status NCT03838484
Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia basic_science Not Available terminated NCT01894984
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia Not Available Not Available terminated NCT00780884
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients No drug interventions treatment Not Available completed NCT01425684
Brain Circuits in Schizophrenia and Smoking No drug interventions Not Available Not Available completed NCT02716584
Benefits of Physical Exercise in Schizophrenia No drug interventions treatment Not Available completed NCT03071484
Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of Psychosis No drug interventions treatment Not Available unknown_status NCT00236379
A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder treatment 4 completed NCT03345979
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia treatment 3 completed NCT00283179
Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia treatment 3 completed NCT02087579
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants basic_science 1 completed NCT00761579
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission treatment 4 completed NCT00184379
Effects of Psychoeducation of Relatives to Patients With Serious Mental Illness No drug interventions treatment Not Available completed NCT01551979
Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia No drug interventions treatment Not Available completed NCT04411979
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia No drug interventions treatment Not Available completed NCT02105779
Optimizing Cognitive Remediation Outcomes in Schizophrenia No drug interventions treatment Not Available completed NCT03288779
Theta Burst Stimulation for Schizophrenia No drug interventions treatment Not Available completed NCT00742079
Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia treatment 4 completed NCT01979679
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone treatment 3 completed NCT02055287
Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder No drug interventions treatment 1 completed NCT01801787
Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia No drug interventions treatment Not Available completed NCT06484387
Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals With a Diagnosis of Schizophrenia. No drug interventions basic_science Not Available not_yet_recruiting NCT02204787
Treatment of Negative Symptoms and Schizophrenia No drug interventions treatment 1 / 2 completed NCT03971487
Ocrelizumab for Psychosis by Autoimmunity treatment 1 / 2 recruiting NCT03465787
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia treatment 3 completed NCT06182787
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient No drug interventions Not Available Not Available recruiting NCT00000387
Self-Management Therapy for Youth With Schizophrenia No drug interventions treatment 3 completed NCT00750087
Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR No drug interventions Not Available Not Available completed NCT05389787
Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study No drug interventions treatment Not Available recruiting NCT00232687
A Switch Study of BMS-337039 in Schizophrenic Out-patients treatment 4 completed NCT01077687
Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan No drug interventions Not Available Not Available completed NCT03092687
Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core No drug interventions Not Available Not Available terminated NCT01617187
A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) treatment 3 completed NCT02051387
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study treatment 1 completed NCT00254787
Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients treatment 2 completed NCT01817387
Enhancing Motivation in Recent Onset Schizophrenia No drug interventions treatment Not Available terminated NCT00573287
First Episode Schizophrenia and Cannabis-Related Disorder Study treatment Not Available completed NCT02248987
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia No drug interventions Not Available Not Available completed NCT01377233
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia treatment 2 completed NCT03188133
Visual Information Processing in Schizophrenia Patients With Visual Hallucinations No drug interventions basic_science Not Available unknown_status NCT00376233
Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia No drug interventions Not Available Not Available completed NCT02709733
Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia No drug interventions treatment Not Available completed NCT00159133
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia treatment 4 completed NCT02331433
Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects No drug interventions treatment 1 completed NCT03544333
Boost rTMS for Auditory Verbal Hallucinations No drug interventions treatment Not Available terminated NCT02072954
Bioequivalence Fasting Study in Patients treatment 2 / 3 completed NCT03900754
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia treatment 2 terminated NCT00815854
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects No drug interventions other Not Available completed NCT04072354
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia treatment 3 completed NCT01672554
Clinical Benefits of Seroquel XR in Anxiety Disorder